The effects of danofloxacin and tilmicosin on peripheral neutrophils in healthy cattle, on peripheral neutrophils in cattle with induced Pasteurella haemolytica pneumonia, and on body temperature measured via radiotelemetry in cattle with induced Pasteurella haemolytica pneumonia by Fajt, Virginia R.
Retrospective Theses and Dissertations Iowa State University Capstones, Theses andDissertations
2000
The effects of danofloxacin and tilmicosin on
peripheral neutrophils in healthy cattle, on
peripheral neutrophils in cattle with induced
Pasteurella haemolytica pneumonia, and on body
temperature measured via radiotelemetry in cattle
with induced Pasteurella haemolytica pneumonia
Virginia R. Fajt
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/rtd
Part of the Pharmacology Commons, and the Veterinary Medicine Commons
This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University
Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University
Digital Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Fajt, Virginia R., "The effects of danofloxacin and tilmicosin on peripheral neutrophils in healthy cattle, on peripheral neutrophils in
cattle with induced Pasteurella haemolytica pneumonia, and on body temperature measured via radiotelemetry in cattle with induced
Pasteurella haemolytica pneumonia " (2000). Retrospective Theses and Dissertations. 13896.
https://lib.dr.iastate.edu/rtd/13896
INFORMATION TO USERS 
This manuscript has been reproduced from the microfilm master. UMI films 
the text directly from the original or copy submitted. Thus, some thesis and 
dissertation copies are in typewriter face, while others may be from any type of 
computer printer. 
The quality of this reproduction is dependent upon the quality of the 
copy submitted. Broken or indistinct print, colored or poor quality illustrations 
and photographs, print bleedthfough, substandard margins, and improper 
alignment can adversely affect reproduction. 
In the unlikely event that the author did not send UMI a complete manuscript 
and there are missing pages, these will be noted. Also, if unauthorized 
copyright material had to be removed, a note will indicate the deletion. 
Oversize materials (e.g., maps, drawings, charts) are reproduced by 
sectioning the original, beginning at the upper left-hand comer and continuing 
from left to right in equal sections with small overiaps. 
Photographs included in the original manuscript have been reproduced 
xerographically in this copy. Higher quality 6' x 9" black and white 
photographic prints are available for any photographs or illustrations appearing 
in this copy for an additional charge. Contact UMI diractiy to order. 
Bell & Howell Information and Learning 
300 North ZMb Road, Ann AriMr, Mi 48106>1346 USA 
800-521-0600 

The effects of danofloxacin and tilmicosin on peripheral neutrophils in healthy cattle, 
on peripheral neutrophils in cattle with induced Pasteurella haemolytica pneumonia, and 
on body temperature measured via radiotelemetry in cattle 
with induced Pasteurella haemolytica pneumonia 
by 
Virginia R. Fajt 
A dissertation submitted to the graduate faculty 
in partial fulfillment of the requirements for the degree of 
DOCTOR OF PHILOSOPHY 
Major: Physiology (Pharmacology) 
Major Professors: Michael D. Apley and Donald C. Dyer 
Iowa State University 
Ames, Iowa 
2000 
Copyright © Virginia R. Fajt, 2000. All rights reserved. 
UMI Number 9962812 
Copyright 2000 by 
Fajt, Virginia R. 
All rights reserved. 
UMI^  
UMI Microfonfn9962812 
Copyright 2000 by Bell & Howell Information and Learning Company. 
All rights reserved. This microform edition is protected against 
unauthorized copying under Title 17, United States Code. 
Bell & Howell Information and Learning Company 
300 North Zeeb Road 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346 
u 
Graduate College 
Iowa State University 
This is to certify that the Doctoral dissertation of 
Virginia R. Fajt 
has met the dissertation requirements of Iowa State University 
Co-major Professor 
Co-major Professor 
For the Major Program 
For the Graduate College 
Signature was redacted for privacy.
Signature was redacted for privacy.
Signature was redacted for privacy.
Signature was redacted for privacy.
iii 
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS v 
ABSTRACT vi 
CHAPTER 1. GENERAL INTRODUCTION I 
Dissertation Organization I 
Literature Review 2 
References 14 
CHAPTER 2. EFFECTS OF DANOFLOXACIN AND TILMICOSIN ON 
CIRCULATING NEUTROPHILS IN BEEF HEIFERS 21 
Abstract 21 
Introduction 21 
Materials and Methods 24 
Results 29 
Discussion 31 
References 34 
CHAPTER 3. DEVELOPMENT OF AN INDUCED PASTEURELLA PNEUMONLV 
MODEL IN WEANED BEEF CALVES 66 
Abstract 66 
Introduction 67 
Materials and Methods 70 
Results 77 
Discussion 79 
References 83 
CHAPTER 4. THE EFFECTS OF DANOFLOXACIN AND TILMICOSIN ON 
NEUTROPHIL FUNCTION AND LUNG CONSOLIDATION IN BEEF CALVES 
WITH INDUCED PASTEURELLA PNEUMONIA 93 
Abstract 93 
Introduction 94 
Materials and Methods 96 
Results 102 
Discussion 105 
Reference List 109 
CHAPTER 5. THE EFFECT OF DANOFLOXACIN AND TILMICOSIN ON CORE 
BODY TEMPERATURES IN BEEF CALVES WITH INDUCED PASTEURELLA 
PNEUMONIA 124 
Abstract 124 
Introduction 125 
Materials and Methods 126 
iv 
Results 130 
Discussion 132 
References 135 
CHAPTER 6. GENERAL CONCLUSIONS 142 
APPENDDC 1. INSTRUCTIONS FROM CELL DEATH DETECTION KIT 145 
APPENDDC 2. INDIVIDUAL CALF TEMPERATURE PROFILES FROM 
CHAPTERS 150 
V 
ACKNOWLEDGEMENTS 
Special thanks are extended for technical assistance provided by Drs. Claire Andreasen and 
Steve Sorden, as well as Tanya LeRoith, Eric Faber, Tom Skadow, Joanne Kinyon, Dee 
Murphy and Phyllis Fisher. In addition, the financial support of Pfizer Animal Health, Lee's 
Summit, Missouri, is acknowledged. 
vi 
ABSTRACT 
Three studies are described in this report. In the first study, the effects of 
danofloxacin and tilmicosin on neutrophil function were examined in healthy mixed-breed 
weaned beef heifers. Neutrophils were isolated from peripheral blood samples pre- and post-
treatment. The neutrophil flmction assays performed were: random migration under agarose. 
Cytochrome C reduction, iodination. Staphylococcus aureus ingestioi., chemotaxis under 
agarose, and antibody-independent and antibody-dependent cell-mediated cytotoxicity. The 
results suggest that at therapeutic drug concentrations, danofloxacin and tilmicosin have little 
clinical effect on bovine neutrophil function. In the second study, a model was developed for 
the induction of pneumonic pasteurellosis (using 6 x lO' CFU of a log-phase culture of 
Pasteurella haemolytica intrabronchially) in weaned, pre-conditioned beef calves that 
consistently produced rectal temperatures of at least 40°C 24 hours after bacterial challenge, 
a clinical score of >1, and measurable lung consolidation. In the third study, Pasteurella 
pneumonia was induced in weaned beef heifer calves using the model from the second study, 
and calves were treated with danofloxacin or tilmicosin. Neutrophils were collected at 3,24 
and 48 hours after treatment. Neutrophil function assays were as performed in study 1, and 
apoptosis was determined using a cell death detection kit. The results suggest that 
danofloxacin and tilmicosin have no clinically significant effects on neutrophil function or 
apoptosis. There were also no significant differences in percent lung consolidation among 
treatments. Significant differences were found between non-challenged calves and the 
challenged non-treated calves in several neutrophil assays, which were attributed to an effect 
of the Pasteurella infection. Body temperature was also examined in this study via 
intravaginally implanted radiotransmitters. Temperatures were monitored prior to challenge 
vii 
until necropsy at 72 hours after treatment. The areas under the curve of the temperature-time 
plot (and over a baseline temperature established for each animal) calculated for 3-hour 
intervals were not significantly different for any of the time intervals when challenged 
animals were compared. Analysis of the mean 3-hour interval temperatures showed 
significantly higher temperatures for saline-treated as compared to antimicrobial-treated 
animals for the majority of the time intervals, but no differences were found bet^veen the 
danofloxacin- or tilmicosin-treated animals. 
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CHAPTER 1. GENERAL INTRODUCTION 
Dissertation Organization 
This dissertation is presented in an introductory chapter, four chapters corresponding 
to papers prepared for submission for publication, and a final chapter of general conclusions. 
The chapters are presented in the order in which the experiments were performed, but also in 
an order that is logical in terms of how to interpret the data gathered. The second chapter 
presents the study that evaluated the effects of the two antimicrobials on the functions of 
circulating peripheral neutrophils in healthy cattle. The third chapter is a discussion of the 
Pasteurella pneumonia induction model and its development. This study was needed to 
verify that pneumonia could be reliably and consistently induced in the age and class of cattle 
utilized. The fourth chapter presents the study in which the effects of the two antimicrobials 
were evaluated in animals with pneumonia. The interpretation of these results was facilitated 
by the completion of the first study, since healthy and diseased animals could then be 
compared. The fifth chapter presents the body temperature information collected via 
radiotelemetry at the same time neutrophil function information was gathered in the third 
chapter. This information is a useful addition to the literature on Pasteurella pneumonia in 
characterizing the temperature response of cattle, and is also presented as another method of 
comparing therapies used in the treatment of pneumonia caused by Pasteurella haemolytica 
in cattle. 
The co-authors on the submitted manuscripts contributed in the following ways: 
Michael D. Apley was the major professor and involved in all aspects of the studies including 
study design, data collection and analysis. James A. Roth was the immunologist involved in 
study design for all studies involving neutrophil function, and personnel in his laboratory 
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performed ail the neutrophil assays. Dagmar E. Frank performed the majority of the 
neutrophil assays including the various attempts at isolating neutrophils from lungs in 
Chapter 2. Kim A. Brogden prepared and administered the Pasteiirella cultiu-es for Chapters 
2-4. Terry L. Skogerboe was the Study Monitor from Pfizer Animal Health, the sponsoring 
organization, and was involved in study design, data collection, and data analysis. Valerie K. 
Karle and Arthur D. Dayton were the statisticians from Pfizer Animal Health and were 
involved in study design and data analysis. 
Literature Review 
As long as antimicrobials have been available clinically, there has been interest in 
their effects on the immune system. The major classes of effects include their toxicity to 
neutrophils, their ability to modify bacterial virulence at subtherapeutic or supratherapeutic 
concentrations, and their modulation of phagocyte fiinction.' The focus of the studies 
reported in this dissertation was the third type of effect, the modulation of phagocyte 
function, specifically the neutrophil. 
Neutrophils are one arm of the non-specific immune system and are recruited to the 
site of bacterial and viral infections in advance of the humoral and cell-mediated responses.* 
In addition, once humoral or cell-mediated immunity is stimulated, neutrophil activity may 
be enhanced." Neutrophils function in several ways to fight infectious agents: They kill 
microbes via oxygen-dependent and oxygen-independent mechanisms, and they kill cells 
infected with agents such as viruses via antibody-dependent and antibody-independent 
mechanisms.^ The oxygen-independent killing mechanisms are mostly related to the 
cytoplasmic granules found in neutrophils, some examples being proteases, elastases and 
glutathione peroxidase. The oxygen-dependent killing mechanism utilizes a membrane-
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associated enzyme complex to convert oxygen to superoxide anion which is subsequently 
converted to hydrogen peroxide, hydroxyl radical, and singlet oxygen, all of which are 
bactericidal. Hydrogen peroxide is also utilized via the myeloperoxidase-hydrogen peroxide-
halide system in the halogenation and oxidation of bacterial surface components resulting in 
potent bactericidal activity." 
Many methods of measuring the functional abilities of neutrophils have been 
studied. These methods all require the isolation of neutrophils from the blood or other 
tissues. Characterizing the effects of various compounds or cytokines on neutrophils is 
accomplished either by isolation of the neutrophils and subsequent application of the 
treattnent {in vitro) or by application of the treatment in the animal or human and subsequent 
isolation of the neutrophils (ex vivo), since functional ability cannot be assessed to a great 
extent in vivo. In general, the following flmctions of neutrophils can be evaluated through 
laboratory efforts: the ability to migrate to the site of infection (chemotaxis), the ability to 
phagocytose bacteria, the ability to kill infectious agents directly through oxygen-dependent 
and oxygen-independent mechanisms, and the ability to kill cells infected with infectious 
agents. The ability to migrate can be evaluated by measuring migration toward a 
chemotactic substance under agarose or using a Boyden chamber (upper and lower chambers 
separated by a membrane).^ The ability to phagocytose can be evaluated using various 
pathogens, such as Staphylococccus aureus, with the amount phagocytosed measured by 
either staining or radiolabeling the pathogen.^'^ Bacterial killing can be assessed by 
measuring actual bacteria killed. The oxygen-dependent bacterial killing mechanisms can be 
evaluated by measuring the production of superoxide anions indirectly via 
chemiluminescence, the reduction of cytochrome C or the reduction of nitroblue tetrazolium 
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reduction. The myeloperoxidase-hydrogen peroxide-halide system (oxygen-independent 
killing) can be evaluated by measuring iodination of opsonized zymosan or by directly 
measuring the activity of myeloperoxidase once it is released from the neutrophils.^ "* The 
ability to kill cells (antibody-dependent and antibody-independent cell-mediated cytotoxicity) 
can be evaluated using radio-labeled chicken red blood cells as targets in the presence or 
absence of specific antibodies.^ 
Utilizing these assays, the effects of various antimicrobials on the functional ability 
of neutrophils have been evaluated. In humans, these efforts have been both in vitro and ex 
vivo, whereas in cattle, the majority of the studies have been in vitro. The effects of the 
major categories of antimicrobials on human neutrophils have been reviewed and will not be 
completely summarized here.^'^ However, the effects of the two classes of antimicrobial 
(macrolides and fluoroquinolones) used in the studies presented in this dissertation will be 
summarized herein, both for human neutrophils and for cattle. The selection of 
antimicrobials for the studies reported in this dissertation was based on several factors: 1) the 
interest of the sponsoring agency in their product, danofloxacin, 2) the fact that some work 
suggested a modulating role of the macrolide tilmicosin on neutrophil flmction, and 3) the 
fact that both drugs are approved for the treatment of respiratory disease in cattle, tilmicosin 
in the US and Europe, and danofloxacin in South America and Europe. 
The macrolide antimicrobials have been extensively studied for their ability to alter 
neutrophil function, particularly since they possess an ability to enter phagocytes easily. 
Although differing techniques used to measure function may alter the results, in general, the 
oxidative functions of human neutrophils have been shown to be inhibited in vitro by 
roxithromycin, dirithromycin, and erythromycin.^ Erythromycin, a 14-membered ring 
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macrolide, inhibits oxidant production^ but 16-niembered ring macrolides have been shown 
not to inhibit oxidative functions and may in fact produce an increased response.^ Other 
functions that have been shown to be enhanced by macrolides are phagocytosis and bacterial 
killing. Increased chemotaxis has been noted with some macrolides when measured using a 
Boyden chamber, but no effects were noted when measured under agarose.^ These results 
concur with the ex vivo results with therapeutic doses of erythromycin which increased 
chemotaxis.^ 
Studies on macrolides and cattle neutrophils in vitro have shown no effect on 
7 8 phagocytosis with erythromycin, tylosin, or spiramycin. The oxidative activity (measured 
via chemiluminescence) of cattle neutrophils was significantly reduced by erythromycin and 
spiramycin at 1000 ng/ml but not at lower (physiologic) concentrations.' Production of 
superoxide anion (measured via c3^ochrome C reduction) was not reduced by erythromycin 
or spiramycin.' 
In humans, some work shows that fluoroquinolones do not appear to inhibit the 
respiratory burst.^''°'" However, subsequent studies have shown both an enhancement of 
oxidative activity (measured via chemiluminescence or superoxide anion production)'^"'®, 
and a reduction in superoxide anion production.'^ Most work indicates that in humans 
fluoroquinolones do not affect chemotaxis, with the drugs tested being nadifloxacin, 
norfloxacin, ofloxacin, pefloxacin, cinoxacin, enoxacin, and ciprofloxacin.'®"'® In contrast, 
fleroxacin was shown to significantly reduce chemotaxis." Differing results have been 
reported as to the effects of fluoroquinolones on phagocytosis: Enoxacin and lomefloxacin 
were shown to enhance phagocytosis of Staphylococcus aureus; ciprofloxacin, pefloxacin, 
norfloxacin, and ofloxacin were shown to suppress phagocytosis of Candida albicans; and 
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enoxacin and ciprofloxacin were shown to have no effect on phagocytosis of S. aureus. There 
has also been a suggestion of a synergistic effect between oxygen-dependent mechanisms 
and the fluoroquinolones in the elimination of the intracellular pathogen S. aureus, although 
non-treated neutrophils were not examined in this paper.*° Apparently, many of the effects of 
fluoroquinolones are drug dependent rather than antimicrobial-class dependent. 
In cattle neutrophils, several fluoroquinolones, including norfloxacin, pefloxacin, and 
ciprofloxacin, have shown no effect on phagocytosis.^ The oxidative activity (measured via 
chemiluminescence) was significantly reduced by danofloxacin (at 100 and 1000 |ag/ml), but 
was significantly increased by enrofloxacin (at 10 and 100 |ig/ml).' Superoxide anion 
production (measured via cytochrome C reduction) was significantly reduced by 
danofloxacin at 1000 |ig/ml.' Danofloxacin significantly reduced myeloperoxidase activity 
at 1000 ^ig/ml."' 
The majority of the studies described above on the effects of antimicrobials on 
neutrophils were conducted in the absence of on-going infectious processes; neutrophils were 
generally collected from healthy animals. This approach allows the delineation of the effects 
of the antimicrobials themselves, but fails to address the potential effects on neutrophils in 
diseased animals. The problem is that infectious agents on their own can have considerable 
effects on neutrophils in the absence of an antimicrobial. The problem is confounded even 
further by the fact that, obviously, infectious processes have potent effects on the immune 
system, which can have subsequent effects on neutrophil function. This complication aside, 
we must at least examine the overall effects of infectious agents and the immune response on 
neutrophil function in the absence of treatment. In this dissertation, the infectious agent 
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examined was Pasteurella haemolytica as a cause of respiratory disease in cattle so the 
discussion will be limited to that agent. 
To put in perspective the importance of respiratory disease in beef cattle, it has been 
reported as the most costly disease, with an estimated annual loss approaching SI billion, and 
an estimated annual cost of prevention and treatment of S3 billion." The losses occur due to 
actual death loss as well as loss of performance: average daily gain of animals with lung 
lesions caused by Bovine Respiratory Disease has been shown to be significantly lower than 
animals with no lung lesions."^'""* Bovine Respiratory Disease (BRD) refers to a syndrome 
that has been associated with several viruses and bacteria in conjunction with some 
compromise to the respiratory defense system caused by environmental, nutritional and 
management factors. The most commonly isolated bacterial pathogens in feedlot cattle, and 
the pathogens for which treatment with an antimicrobial is instituted, are Pasteurella 
haemolytica and Pasteurella multocida with the latter more commonly isolated from younger 
cattle." 
Because of the importance of this disease complex in cattle production, hundreds of 
trials have been conducted to elucidate its pathogenesis, prevention, diagnosis, and treatment. 
Many of these trials are performed using experimental models of the disease rather than the 
naturally occurring disease in order to control elements such as the timing of treatment. 
Therefore, there are on-going efforts to develop disease models that more closely mimic the 
syndrome as it appears in the clinical setting. These induction models have included 
applications of a stressor prior to instillation of bacteria, e.g., mechanical (acetic acid," cold 
water," exercise^^ and viral,*^ as well as numerous methods of instillation of bacteria 
8 
(aerosol/® transtracheal via needle"' or catheter,^" transthoracic via needle,^' intrabronchial 
via endoscopy^^ or some type of endobronchial tube^^). 
For the purpose of our study, we needed a Pasteurella pneumonia induction model 
that fulfilled the following criteria: It must be applicable to weaned beef cattle 
approximately 6 months in age, it must be fast, consistent and reproducible, it must not 
require multiple pathogens or multiple applications of bacteria, it must not require knowledge 
of previous exposure (i.e., unknown P. haemolytica litres), it must not require anesthesia, and 
it must not require specialized equipment such as endoscopy. In addition, we had an interest 
in using a well-defined clinical case definition in order to contribute to a continuing effort to 
standardize clinical trials for pharmaceutical agents. One method of standardizing case 
definitions of bovine respiratory disease is to observe animals from a moderate distance and 
assign a clinical score based on an established scale^"* from 0-4: In this scoring system, 0 is 
normal with no clinical signs of disease, 1 is noticeable depression without signs of 
weakness, 2 is marked depression with moderate signs of weakness, 3 is severe depression 
with signs of weakness such as altered gait, and 4 is moribund and unable to rise. At the 
selected time of 24 hours after instillation of the inducing bacteria, an animal was considered 
to have respiratory disease if it had a clinical score of I or greater and a rectal temperature of 
40°C or greater. Therefore, we performed a separate study (reported in Chapter 3) to develop 
and verify the model we intended to apply. 
The pathogenesis of BRD is complicated even if we limit the discussion to 
Pasteurella haemolytica infection, and includes interactions of neutrophils, macrophages, 
lymphocytes, cytokines, adhesion molecules, and antimicrobial peptides. However, in all 
stages of the bacterial infection, the neutrophil plays a significant role, both in fighting 
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infection and in contributing to lung damage. There is evidence that neutrophil-depleted 
calves have decreased lung damage when experimentally infected with P. haemolytica, 
suggesting neutrophil enhancement of lesions.^^ Conversely, there is evidence that 
neutrophil-depleted calves have more widespread lesions than normal calves, implying that 
the role of the neutrophil in the pathogenesis of P. haemolytica infection is complicated.'" In 
addition, it appears that not all of the extensive damage to the lungs can be blamed on 
neutrophils, since neutrophil-depleted animals still have significant disease.^' However, it 
can be stated that neutrophils play a significant role in the pathogenesis of the P. haemolytica 
infection associated with BRD. 
Because of this intimate association of neutrophils with Pasteurella infection, the 
effect of the bacteria directly on neutrophil fiinction becomes important. And as mentioned 
above, if we are going to examine the effect of antimicrobials on neutrophil function in 
Pasteurella infection, we need to understand the effects oiPasteurella alone. It is known 
that the leukotoxin produced by P. haemolytica is cytotoxic to neutrophils, suggesting a 
virulence mechanism advantageous to the bacteria.^® In addition, P. haemolytica and its 
products have been shown to have the following in vitro effects on the functional abilities of 
neutrophils: Culture fluid firom P. haemolytica has been shown to induce chemotaxis,^' "^, as 
have isolated outer membrane proteins,"" whereas P. haemolytica lysate or cultures had no 
effect on chemotaxis."*' Oxidative activity (measured by chemiluminescence or cytochrome 
C reduction) has been shown to be induced by culture fluid fi-om P. haemolytica^^, by 
washed P. haemolytica cultures,'*^ and by isolated leukotoxin in most cases.''^^ In some 
experiments, the activation of the oxidative response was followed by rapid diminution of the 
response, when isolated leukotoxin'*® '*® or washed P. haemolytica cultures were used.^' 
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Extracts of P. haemolytica, including lipopolysaccharide,"° purified capsular 
polysaccharide/* and outer membrane proteins, have been shown to decrease phagocytosis/' 
Comparatively few data are available on the effects of P. haemolytica infection in vivo on 
neutrophils. Chemotaxis was found to be diminished in animals with induced P. haemolytica 
pneumonia, but no other differences were noted.^" 
In the context of neutrophils and their association with the destruction of lung tissue, 
it has been suggested that if neutrophils could be induced to undergo a controlled death such 
as apoptosis rather than a relatively uncontrolled death leading to release of toxic metabolites 
such as occurs with necrosis, the damage to the lungs might be reduced.^^"^"* In addition, 
attenuation of apoptosis has been shown to reduce inflammation in a model of endotoxin-
induced liver injury.On the other hand, loss of neutrophils at a critical stage could lead to a 
diminished immune response and result in overwhelming infection as occurs in animals with 
defective or depleted neutrophils.^^ Perhaps apoptosis is beneficial only at a certain stage in 
the infectious process. Nonetheless, it is an area of immunology that has received 
considerable attention recently. 
Apoptosis has been called programmed cell death and is a highly regulated process 
resulting in cell shrinkage or splitting into vesicles with little spillage of cell contents.^"* 
Typical features of apoptosis are membrane blebbing, nuclear condensation, and DNA 
fi^gmentation.^^ Bacterial pathogens have differing effects on apoptosis, with some species 
inducing and some inhibiting apoptosis in leukocytes.^^ Pasteurella haemolytica has been 
shown to induce apoptosis in vitro^'^^ and in vivo in an induced pneumonia model.®® 
Whether or not apoptosis is desirable in the context of P. haemolytica pneumonia 
may not be answered yet, but its mere presence in this disease suggests that we should 
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evaluate the effects of administered compounds such as antimicrobials on this aspect of the 
immune process. One study suggested that tilmicosin administered in experimental P. 
haemolytica pneumonia induced apoptosis of neutrophils.^® These investigators suggest an 
anti-inflammatory benefit to tilmicosin, although this remains to be borne out. The difficulty 
with this type of ex vivo study is that the effects of the antimicrobial are confounded with the 
effects of the Pasteurella. Our answer to help resolve those effects was to perform two ex 
vivo studies using tilmicosin and another antimicrobial, danofloxacin: one in healthy animals 
(Chapter 2) and one in pneumonic animals (Chapter 4). This method could potentially shed 
light on whether the antimicrobials had direct effects on apoptosis and neutrophil function. 
Because bacterial disease was induced in calves in this study, there was an 
opportunity to evaluate other clinical findings in the animals. As evidenced by the clinical 
criteria used in these experiments, it is well known that body temperature rises as a result of 
infection with Pasteurella haemolytica. Bacterial infections in general result in the release of 
pyrogenic cytokines such as IL-1, tumor necrosis factor and IL-6 firom macrophages and 
other cells into the general circulation. It is believed that these cytokines act directly or 
indirectly on the vascular network close to the hypothalamus to produce prostaglandin E 
(PGE) via the arachidonic acid cascade.^' PGE acts on the thermoregulatory center to cause 
a change in the set-point, resulting in systemic responses that increase body temperature such 
as vasoconstriction and shivering." The measurement of body temperature is therefore used 
to monitor whether infection is occurring or whether the infection is being cleared. 
In addition to the rectal temperatures measured at the time of treatment of animals, a 
remote method of evaluating body temperature via radiotelemetry was used in these studies. 
Radiotelemetry permits monitoring of body temperature without requiring the handling of 
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animals. In cattle, methods to monitor body temperattire were developed in the 1960s^^ " 
and subsequently refined over time. Now available to the scientist without an electronics and 
radio background are self-enclosed hermetically sealed transmitters that can be placed 
virtually anywhere in an animal, from the peritoneum to the vagina.^^ Systems are 
commercially available that allow automatic downloading of temperature data onto computer 
hard disk.' hi addition, advancements in computer technology now allow the handling of 
large amounts of data using a desktop system, so that temperature can be recorded as often as 
desired and then be analyzed on the average personal computer. 
Core body temperature has been measured in normal cattle to evaluate estrual patterns 
of temperature in dairy*^®'*^' and beef cows:^® Body temperature rises at least 0.3°C for at least 
3 hours during ovulation. Core body temperature response in beef and dairy cattle to climate 
such as heat in the summer*^^"®^'™ or cold in the winter^' has been evaluated. It appears that in 
feedlot steers, there is a circadian pattem to core body temperature. In the winter, body 
temperature minima were at approximately 8 a.m. and maxima at approximately 7 p.m.'' In 
the summer, the peak and trough temperatures occurred at similar times (8 a.m. and 6:30 
p.m.), but daily minimum temperatures actually decreased slightly with an increase in 
ambient temperature, suggesting a compensatory mechanism to promote heat loss at night in 
anticipation of increased ambient temperatures during the day.®' The importance of normal 
body temperature variation becomes evident when attempts are made to evaluate body 
temperature during disease. 
The use of continuously recorded body temperature in response to disease in cattle 
has been more limited. The only reports found were of induced clinical mastitis in Hairy 
' DatacolS® Large Animal Monitoring Software, Miniminer Co., Sunriver, Oregon 
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cowsP'^^ The temperature response to Pasteurella pneumonia and its treatment has been 
evaluated via rectal temperature. However, convenience and handling facilities dictate 
limited data collection, particularly in the case of larger calves such as those used in our 
studies (average weight of approximately 400 lbs.). In addition, it could be argued that 
handling animals many times a day could affect their response to treatment due to additional 
stress. Therefore, our study on the effects of induced Pasteurella pneumonia in beef calves 
and its treatment on neutrophil function was expanded to include the evaluation of body 
temperature. It was hoped that continuously recorded body temperature might be a valuable 
tool in the assessment of response to pharmaceutical products with potential expansion to 
vaccine efficacy. 
The major objectives of the studies reported in the following chapters were as 
follows: 
(1) To characterize the effects on ex vivo neutrophil function of two antimicrobials, 
danofloxacin and tihnicosin, in healthy weaned beef heifers 
(2) To develop a model of inducing Pasteurella haemolytica pneumonia in weaned beef 
heifers that resulted in an adequate number of animals exhibiting the desired case criteria 
(3) To characterize the effects on ex vivo neutrophil function of danofloxacin and tilmicosin 
in weaned beef heifers with induced P. haemolytica pneumonia 
(4) To characterize the effect of P. haemolytica pneumonia on continuously recorded body 
temperature of weaned beef heifers, and to determine if this method of monitoring can be 
used in comparative trials of pharmaceuticals or biologicals. 
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CHAPTER 2. EFFECTS OF DANOFLOXACIN AND TILMICOSIN ON 
CIRCULATING NEUTROPHILS IN BEEF HEIFERS 
A paper submitted to the Journal of Veterinary Pharmacology and Therapeutics 
Virginia R. Fajt, Michael D. Apley, James A. Roth, Terry L. Skogerboe, 
Valerie K. Karle, Arthur D. Dayton 
Abstract 
The in vivo effects of two antimicrobials, danofloxacin and tilmicosin, on neutrophil 
function and hematology parameters were examined. The labeled doses of each drug, or 
sterile saline, were administered to healthy mixed-breed weaned beef heifers approximately 6 
months of age. Neutrophils were isolated from peripheral blood samples at 108 and 60 hours 
pre-treatment, and 12, 36, and 60 hours post-treatment. The neutrophil function assays 
performed were: random migration under agarose. Cytochrome C reduction, iodination. 
Staphylococcus aureus ingestion, chemotaxis under agarose, and antibody-independent and 
antibody-dependent cell-mediated cytotoxicity. The results suggest that at therapeutic drug 
concentrations, danofloxacin and tilmicosin have little clinically significant effect on bovine 
neutrophil function. 
Introduction 
Antimicrobials are relied on to kill or inhibit the growth of bacteria at a site of 
infection. Recent investigations into the effects of antimicrobials on host cells involved in 
the immune response have suggested additional roles for certain antibacterial compounds, 
e.g., modulation of neutrophil function (Labro, 1998). Neutrophils are an arm of the non­
specific immune system and contain several mechanisms for bacterial killing. During the 
normal response to an infectious process, neutrophils marginate, diapedese through the 
22 
vascular wall, migrate via chemotaxis to the site of infection, and perform their killing 
functions. A battery of assays allows the evaluation of many of these steps (Roth, 1993). See 
Table 1 for an overview of these assays. 
The importance of neutrophils in the initial line of defense in bacterial infections 
cannot be overlooked; however, in some cases an influx of neutrophils may do more harm 
than good. In the case of bovine pneumonic pasteurellosis, there is evidence to suggest that 
neutrophil infiltration into the lungs is responsible for a large portion of the lung damage in 
advanced disease (Slocombe et al., 1985;Breider et al., 1988). Therefore, products that 
inhibit the response of neutrophils to infections might be advantageous under these 
circumstances. 
The bulk of the investigations into the effects of antimicrobials on neutrophil 
function have involved in vitro exposure of isolated neutrophils to the antimicrobial, 
followed by assays of function or morphological examination of the cells (Ziv et al., 
1983;Nickerson et al., l985;Paape & Miller, I990;Paape et al., 1991;Hoeben et al., 
l997a;Hoeben et al., 1997b;Hoeben et al., 1998). The difficulty associated with clinical 
application of these studies is that the concentration of antimicrobial added in vitro is often 
much higher than the achievable concentration in the animal, even in tissues where lipid 
soluble antimicrobials might be expected to accumulate. For example, the lipid-soluble 
antimicrobial tiknicosin has been demonstrated to accumulate in bovine neutrophils at 40 
times the extracellular concentration when the extracellular concentration was 5 ^g/ml 
(Scomeaux & Shryock, 1999). However, the actual maximal serum concentration (Cmax) of 
tihnicosin in bovine serum has been reported as 0.873 |ig/ml (Modric et al., 1998), 
suggesting a neutrophil intracellular concentration of approximately 35 ^g/ml, which is 
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considerably lower than the concentrations shown to significantly affect neutrophil function 
in the in vitro studies (Ziv et al., 1983;Nickerson et al., l985;Paape & Miller, 1990;Paape et 
al., 1991;Hoeben et al., 1997a;Hoeben et al., 1997b;Hoeben et al., 1998). 
Several studies have evaluated the ability of antimicrobials to modulate bovine 
neutrophil function, although only the effects of macrolides and fluoroquinolones will be 
described. Differences in the phagocytosis of radio-labeled Staphylococcus aureus by 
neutrophils were not significant among non-treated and erythromycin-treated neutrophils 
isolated from bovine milk with erythromycin concentrations of 1000,500,10 or 1 ng/ml (Ziv 
et al., 1983;Nickerson et al., 1985), nor among non-treated and quinolone-treated neutrophils 
at concentrations of 1000, 500 and 10 jag/ml (Paape et al., 1991). To compare in vitro 
concentrations with those actually achieved in vivo in the serum, it should be noted that 
maximal serum concentration of danofloxacin in cattle after intramuscular dosing of 5 mg/kg 
was 0.83 )Ag/ml (Mann &, Frame, 1992). Lung concentrations after 5 mg/kg intramuscularly 
approached 5 ng/g (Maim & Frame, 1992). The extrapolated initial serum concentration of 
erythromycin after intravenous administration of 15 mg/kg in calves was 23.4 ^ g/ml 
(Burrows, 1985). 
The effects of antimicrobials on phagocytosis of fluorescein-labeled E. coli and on 
respiratory burst activity on bovine neutrophils isolated from peripheral blood were 
examined by Hoeben et al. (Hoeben et al., 1997b). Erythromycin resulted in a decrease in 
phagocytosis only at an extracellular concentration of 1000 (ig/ml, and danofloxacin at any 
level had no effect on phagocytosis. Respiratory burst activity was inhibited by danofloxacin 
at doses of 100 ng/ml and higher and by erythromycin at 1000 (xg/ml. Danofloxacin also 
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decreased myeloperoxidase activity at 1000 fig/ml. Neither erythromycin nor danofloxacin 
had any effect on neutrophil generation of superoxide anion in that study. 
To avoid the concern of applicability of in vitro concentrations to the clinical 
setting, in this study, we evaluated the ability of the antimicrobials danofloxacin (a 
fluoroquinolone) and tilmicosin (a macrolide) to modulate neutrophil function in healthy 
animals. Evaluating therapeutically relevant doses of antimicrobials given to healthy cattle 
provides a baseline for evaluating neutrophil function in cattle with bovine respiratory 
disease or other bacterial diseases that are treated with an antimicrobial. 
Materials and Methods 
The experimental protocol was approved by the Iowa State University Committee on 
Animal Care. Laboratory procedures were conducted according to Good Laboratory 
Practices regulations as established by the Food and Drug Administration. 
Animals 
Thirty-five mixed-breed, weaned beef heifers approximately 6 months of age were 
leased from a herd in southeastern Iowa. Thirty animals were selected for treatment by 
excluding the heaviest and lightest animals to achieve uniformity of size. On the day of 
treatment, the animals weighed from 207-277 kg. The animals had no history of previous 
treatment with any macrolide or fluoroquinolone antimicrobials. 
The animals were permitted an 8-day acclimation period prior to the initial pre-
treatment sample collection. During the study, animals were housed outdoors with an open-
front pole bam as shelter in a space providing approximately 165 square feet per head. They 
were fed free choice hay and a grain supplement containing monensin sodium balanced to 
allow weight gain of approximately 1.5 Ibs/head/day. Prior to sample collection pre- and 
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post-treatment, animals were observed for signs of clinical illness by an investigator masked 
to treatment. 
Treatment 
Pre-treatment blood samples for neutrophil isolation were drawn 4 and 2 days prior 
to treatment with the antimicrobials. A random number from a uniform distribution on the 
interval zero to one was assigned to each of these 30 animals. The animals were then sorted 
by this random number and the first 10 assigned to saline treatment, the next 10 to 
danofloxacin treatment, and the remaining 10 to tilmicosin treatment. 
The antimicrobials were administered at 6 p.m. on Day 0, and blood samples were 
collected for neutrophil isolation 12,26, and 60 hours after drug administration. These time 
periods were selected to allow for the maximal effects of the antimicrobials to be 
demonstrated. 
Antimicrobials 
Danofloxacin mesylate" (180 mg/ml) was given at a dosage of 6 mg/kg 
subcutaneously in the left lateral neck. Tilmicosin'" (300 mg/ml) was given at a dosage of 10 
mg/kg subcutaneously in the left lateral neck. Control animals were treated with 0.9% saline 
in a volume equal to a dose of danofloxacin subcutaneously in the left lateral neck. 
Hematology 
Blood samples were collected via jugular venipuncture and placed in tubes containing 
EDTA™. An automated cell counter' was used to measure total and differential leukocyte 
" Advocin, Pfizer Inc, New York, New York. 
Micotil, Elanco Animal Health, Indianapolis, Indiana. 
" Vacutainer, Becton Dickinson and Co., Franklin Lakes, New Jersey. 
* Cell-Dyne 3500, Abbott Labs, Abbott Park, Illinois. 
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count, erythrocyte count, hematocrit, hemoglobin, mean corpuscular volume, mean 
corpuscular hemoglobin, mean corpuscular hemoglobin concentration, red cell distribution 
width, platelet count, and mean platelet volume. 
Neutrophil isolation 
Blood samples were collected via jugular venipuncture and placed in 50 ml tubes 
with acid-citrate-dextrose. Samples were centrifuged at 600 x g for 30 minutes. The 
plasma, buffy coat and top portion of the red cell layer were aspirated from the samples, 
leaving approximately 10 ml of volume undisturbed in the tube. Red cells were lysed using 
two volumes of phosphate buffered deionized water. Isotonicity was then restored with one 
volume of 2.5% saline. Tubes were centrifuged at 200 x g for 10 minutes and the 
supernatant discarded. The cell pellets were resuspended in 10 ml of phosphate buffered 
saline and counted. Samples were suspended with Hanks balanced salt solution to a 
concentration of 5 x 10^ cells/ml for use in the neutrophil assays. 
Neutrophil assays 
These assays have been previously described (Roth & Kaeberle, I981a;Roth & 
Kaeberle, 1981b;Lukacs et al., 1985;Chiang et al., 1991). Random migration under agarose 
was performed using a modification of the method of Roth and Kaeberle (Roth & Kaeberle, 
1981a). Six holes were punched in agar containing Minimum Essential Medium with Earles 
salts containing 0.8% agarose, 10% fetal calf serum, and 1% antibiotic-antimycotic solution. 
Neutrophils were added to the wells, two samples per animal, and the plates were incubated 
at 39®C in 5% C02, for 18 hours. Plates were then flooded with 8% glutaraldehyde for at 
least one hour. After removing the agar, plates were flooded with 0.1% crystal violet for at 
least 10 minutes in order to stain the cells adhering to the plates. Plates were read on an 
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inverted microscope using the lOx planar objective by measuring the distance in millimeters 
radially from the center of the neutrophil well to the farthest point of random migration. 
The Cytochrome C reduction assay was performed by incubating opsonized 
zymosan with Cytochrome C and neutrophils in Hank's balanced salt solution (HBSS), and 
the optical density of the supernatant at 550 nm was determined. Background values were 
measured by replacing zymosan with HBSS, and then subtracted from the results obtained 
with zymosan. 
For the iodination assay, opsonized zymosan, Nal, and '"^I-Na were pre-warmed in 
Earle's Balanced Salt Solution at 39°C, and neutrophils were added. The tubes were tumbled 
for 20 minutes at 39°C, the reaction stopped with cold 10% trichoroacetic acid, and 
centrifuged for 10 minutes at 1000 g. After discarding the supernatant, the wash was 
repeated, and radioactivity in the neutrophils was measured in a gamma counter" and 
reported as counts per minute (CPM). Results were calculated as follows: 
fCPM for experimental sample) - (CPM for blanks x (40 nmol Nal) x ( l .Ox 10^  neut rophi l s )  x 60 mins 
(CPM for standard sample) (2.5 x lO" neutrophils) 20 mins 
For the S. aureus ingestion assay, heat-killed '"l-labeled S. aureus, anti-5. aureus 
antiserum, and 2.5 x 10^ neutrophils were incubated in Earle's Balanced Salt Solution at 
39°C for 10 minutes. Lysostaphin was added, and the tubes incubated for 30 minutes at 
39°C. The reaction was stopped with PBS, and the tubes centrifuged at 4C for 10 minutes at 
% 
1250 g. After removing the supernatant and repeating the wash procedure, radioactivity 
associated with the neutrophils was measured in a gamma counter in counts/minute (CPM). 
Results were calculated as follows: 
" Cobra Auto-Gamma, Packard Instrument Co., Downers Grove, Illinois. 
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Percent ingestion = (CPM in reaction tube - CPM in background tube) x 100 
(CPM in standard tube - CPM in background tube) 
Chemotaxis was evaluated under agarose, using zymosan activated bovine serum as 
the chemoattractant. After measuring the distance migrated toward Medium 199 (random 
migration) and the distance migrated toward the activated serum (chemotaxis), a chemotaxis 
index was generated by dividing chemotaxis by random migration. 
The antibody-dependent and antibody-independent cell-mediated cytotoxicity assay 
was performed as follows: radiolabeled (^'Cr) chicken erythrocytes (cRBC's) in Medium 199 
were incubated for 2 hours at 37°C in 5% CO2 with neutrophils in the presence or absence of 
anti-cRBC antibody. Triton X, neutrophil only, and antibody controls were included. Each 
animal was represented in quadruplicate. Supernatant was filtered out using a Skatron 
harvester apparatus. Samples were then placed in a gamma counter and read for 2 minutes. 
Results were expressed as a percentage of lysis and calculated as follows; 
% lysis = (Counts per minute in reaction tubeVCCounts per minute in background tube) \ 100 
(Counts per minute in standard tube)-(Counts per minute in background tube) 
Statistical Analysis 
The following variables were natural log transformed prior to analysis: neutrophil 
chemotactic index, mean corpuscular volume, lymphocyte absolute count, monocyte absolute 
count, RDW, mean platelet volume, and mononuclear white blood cell count. The 
transformation resulted in residuals that were more normally distributed and also stabilized 
the variance. The least squares means were then back-transformed after analysis. The 
repeatedly measured neutrophil assay variables were analyzed using a general linear 
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repeated-measures mixed model.^' If a significant difference was detected (p<0.05) due to 
day of study or treatment effect, pairwise comparisons among treatments were made. 
Statistical significance was defined as p<0.05. 
Results 
A significant effect of day of assay was noted for all neutrophil assays except the 
neutrophil chemotactic index, including pre-treatment. However, no statistically significant 
differences were found among treatments on any of the pre- or post-treatment days for the 
following neutrophil assays: neutrophil random migration, percent S. aureus ingestion, 
iodination, unstimulated Cytochrome C reduction, antibody-independent cytotoxicity, or 
antibody-dependent cytotoxicity. (See Tables 2-8 and Figures 1-7 for summaries of results.) 
No statistically significant differences were found among the following blood cell 
parameters: total erythrocyte count, mean corpuscular volume, mean corpuscular 
hemoglobin, mean corpuscular hemoglobin concentration, total lymphocyte count, total 
monocyte count, total eosinophil count, total basophil count, red cell distribution width, or 
mean platelet volume. 
The only neutrophil function assay exhibiting any differences among treatment 
groups was Cytochrome C reduction: The mean optical density of the stimulated cytochrome 
C reduction assay at 60 hours after treatment was lower for tilmicosin than for saline- or 
danofloxacin-treated animals (Table 6, Figure 5). The values on all other days before and 
after treatment were not significantly different. 
Total white blood ceil count was higher for the tibnicosin treatment group as 
compared to saline or danofloxacin at 12 hours post-treatment; least squares means for 
SAS Open VMS version 6.12 for an alpha, 1998, SAS Institute Inc., Gary, North Carolina. 
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controls, danofloxacin-treated and tilmicosin-treated animals were 7.78, 8.63, and 11.39 x 
10^/^l respectively (Table 9, Figure 8). Total white cell count was also higher for the 
tilmicosin treatment group as compared to saline but not danofloxacin at 36 hours after 
treatment. At 12 hours post-treatment, absolute neutrophil count was higher in the tilmicosin 
treatment group as compared to the other two treatments: 3.63, 4.57, and 6.65 x lO'/^l for 
control, danofloxacin- and tilmicosin-treated animals, respectively (Table 10, Figure 9). The 
neutrophil counts were above the normal limits for the danofloxacin- and tilmicosin-treated 
ammals. No other differences among white blood cell parameters were noted at any other 
time. 
Total hemoglobin (Table 11, Figure 10) and hematocrit (Table 12, Figure 11) were 
significantly lower in the danofloxacin treatment group at 12 hours as compared to tilmicosin 
and controls. There were no other differences among erythrocyte parameters at any other 
time point. 
Mean total platelet count was significantly higher in the control group as compared 
to the other two treatment groups at 4 days pre-treatment, and was higher than the upper 
normal limit for cattle reported by the Clinical Pathology Laboratory at Iowa State University 
(848,000 vs. 800,000, respectively) (Table 13, Figure 12). At this time period, the mean 
platelet counts for danofloxacin and tilmicosin were 477,000 and 583,000 respectively. At 2 
days pre-treatment, mean platelet count in the tilmicosin treatment group was significantly 
lower than the saline group although the counts were all within the normal limits (100,000-
800,000). No differences were found among treatment groups at 12,36 or 60 hours after 
treatment. 
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Two animals showed evidence of adverse reactions after treatment with 
danofloxacin. One animal went into lateral recumbency for several minutes, but then 
appeared to recover with no ill effects. The other animal appeared to have an anaphylactoid 
response, was treated appropriately and was removed from the study. 
Discussion 
In this study, circulating neutrophils were collected from calves treated with 
danofloxacin and tilmicosin to evaluate the effect of therapeutic concentrations of these 
antimicrobials on neutrophil function. In addition, hematology was performed to evaluate 
the effect of these two antimicrobials on blood cell counts. 
A large day-to-day variation when performing these assays is expected due to assay 
variability (Roth, 1993). For the majority of assays, no significant differences were noted 
among treatment groups within days. This is in contrast to results obtained in in vitro studies 
using supra-therapeutic concentrations of antimicrobials as discussed above. 
Among the neutrophil assays, the only significant difference among treatment groups 
was in one assay (Cytochrome C reduction) at one blood collection time (60 hours after 
treatment) when the tilmicosin treatment group exhibited a reduction in superoxide anion 
production. This could be explained as a cumulative effect of the tilmicosin: The elimination 
half-life of tilmicosin is approximately 29 hours (Modric et al., 1998), allowing for a long 
exposure time. It is possible that the tilmicosin's effects on neutrophil function require 
extended exposure before changes are noted in neutrophils. However, because there were no 
other consistent differences among the neutrophil assays, this appears to be an anomaly 
rather than a clinically significant statistic. It is likely that the significant decrease in 
Cytochrome C reduction was due to random chance, since it was observed at only one time 
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period. These results are consistent with the findings in an induced-infection model after 
treatment with tilmicosin. In that study, no differences were noted in neutrophils from 
control and tihnicosin-treated animals for phagocytic activity and nitro blue tetrazolium 
reduction, a measure of oxidative function (Chin et al., 1998), although lung neutrophils 
rather than peripheral neutrophils were evaluated. 
At 12 hours post-treatment, tilmicosin-treated animals had significantly higher white 
blood cell counts due to a higher neutrophil count. The total white cell counts were within 
normal limits of the laboratory (4,000-12,000 cells/^1). However, the neutrophil counts were 
above the normal limits for the danofloxacin- and tilmicosin-treated animals. The difference 
in neuU'ophil count was transient, disappearing by 36 hours after treatment, although the 
increase in total white cell count persisted and did not disappear until 60 hours after 
treatment. We found no reports of this phenomenon in the literature for either antimicrobial. 
It did not appear to be related to the stress of handling, since there was no effect on the 
control animals. 
At 12 hours after treatment, hemoglobin and hematocrit were significantly lower in 
the danofloxacin-treated group, although both remained within normal limits for the 
laboratory. There have been reports of fluoroquinolones causing hemolysis in human 
patients: temafloxacin was removed fi-om the market after reports of hemolysis with or 
without organ failure that were associated with an autoimmunity to erythrocytes (Blum et al., 
1994). However, in the present study, the decrease in hemoglobin and hematocrit was 
transient and was never below normal limits for the laboratory, suggesting another, albeit 
unknown, mechanism must have been responsible. 
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The differences among the groups for the pre-treatment platelet counts, although 
statistically significant, did not appear to have clinical significance, particularly since no 
differences were noted after treatment. In addition, since platelet maturation takes 4-5 days, 
and platelet life span is approximately 10 days (Duncan et al., 1994), it seems unlikely that 
the effects noted are due to anything other than clumping during collection, variation in 
counting, or splenic contraction or congestion. 
An argimient could be made that comparing these two drugs, which have very 
different pharmacokinetic and pharmacodynamic parameters, is difficult. The study was 
designed to account for these differences as described below. In addition, the drugs were 
administered in the manner (a single dose) and at the dose they are used clinically, so it 
seems reasonable to compare them in this fashion. 
To account for the pharmacokinetic differences, the times of sample collection were 
selected to allow for the effects of each antimicrobial to be adequately evaluated. Since 
tilmicosin phosphate has a much longer elimination half-life (29.4 hours (Modric et al., 
1998)) as compared to subcutaneous danofloxacin (4.3 hours for a 5 mg/kg subcutaneous 
dose using a 2.5% solution (Mann & Frame, 1992)), samples were collected until 60 hours 
after treatment. 
The pharmacokinetics of the 2 drugs are different: although they peak at similar 
serum concentrations (danofloxacin at 0.83 /ml at 5 mg/kg SC (Mann & Frame, 1992); 
tilmicosin at 0.87 at 10 mg/kg SC (Modric et al., 1998)), their elimination half-lives are 
different. Danofloxacin has an elimination half-life of 4.3 hours (Mann & Frame, 1992), 
whereas tihnicosin has an elimination half-life of 29 hours (Modric et al., 1998). hi addition, 
their pharmacodynamics differ; fluoroquinolones are considered peak- or concentration-
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dependent, meaning that efficacy is associated with a high peak, related to a large area under 
the time-concentration curve, rather than a long duration of serum drug concentration 
(Drusano et al., 1993). In contrast, the efficacy of macrolides is generally considered to be 
related to the time serum concentration remains above the minimum inhibitory concentration 
of the organism (Vogehnan et al., 1988). Whether these kinetics and dynamics are 
applicable to other parameters besides their antimicrobial efficacy remains to be determined. 
The results from this study suggest that at therapeutic drug concentrations, 
danofloxacin and tilmicosin have relatively little effect on the functional abilities of 
circulating neutrophils in healthy animals. 
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Table 1. A description of the function assays performed on neutrophils in this study and their 
interpretation. 
Assay InterpretatioD of assay 
Neutrophil random 
migration 
Increased random migration noted in dexamethasone-treated 
animals; increased random migration implies decreased ability 
to adhere to endothelium 
Neutrophil chemotaxis Low chemotactic index suggests inability to migrate toward 
infection 
Staph ingestion Measures ability of neutrophils to phagocytose bacteria 
Cytochrome C 
reduction 
Evaluates production of superoxide anion; decrease in 
production implies decreased ability to kill bacteria 
lodination Detects dysflmction in the chain of events involving the 
hydrogen peroxide- myeloperoxidase system; decrease implies 
decreased ability to kill bacteria 
Antibody-independent 
cytotoxicity 
Measures cytotoxicity in the absence of antibody 
Antibody-dependent 
cytotoxicity 
Correlates with ability to kill viral infected cells 
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Table 2. The distance neutrophils migrated under agarose in mm'(neutrophil random 
migration assay), reported as least square means and standard error. Neutrophils were 
collected 4 and 2 days before and 12,36 and 60 hours after treatment with danofloxacin, 
tilmicosin or saline. 
Control ± SEM Danofloxacin ± SEM Tilmicosin ± SEM 
4 days pre-treatment 81.9 ±10.7 87.4 ± 11.3 78.2 ± 10.7 
2 days pre-treatment 96.3 ± 10.7 109.9 ± 11.8 100.2 ± 10.7 
12 hours post-treatment 94.7 ± 10.7 115.3 ± 11.3 120.2 ± 10.7 
36 hours post-treatment 102.3 ± 10.7 92.5 ± 11.3 llO.l ± 10.7 
60 hours post-treatment 110.6 ± 10.7 86.2 ± 11.3 91.4 ± 10.7 
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Table 3. Neutrophil chemotaxis reported as chemotactic index with 95% confidence 
intervals. Neutrophils were collected 4 and 2 days before and 12, 36 and 60 hours after 
treatment with danofloxacin, tilmicosin or saline. 
Control Danofloxacin Tilmicosin 
4 days pre-treatment 1.09(1.02-1.16) 1.12(1.05-1.19) 1.16(1.09-1.23) 
2 days pre-treatment 1.16(1.10-1.23) 1.09(1.02-1.15) 1.15(1.09-1.21) 
12 hours post-treatment 1.09(1.04-1.14) 1.15(1.09-1.21) 1.06(1.01-1.11) 
36 hours post-treatment 1.08 (0.97-1.22) 1.12(0.99-1.26) 1.12(1.00-1.26) 
60 hours post-treatment 1.20(1.11-1.30) 1.20(1.10-1.32) 1.12(1.04-1.22) 
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Table 4. Percent radiolabeled S. aureus ingested by neutrophils {Staphylococcus ingestion 
assay) reported as least-squares means and standard error. Neutrophils were collected 4 and 2 
days before and 12, 36 and 60 hours after treatment with danofloxacin, tilmicosin or saline. 
Control ± SEM Danofloxacin ± SEM Tilmicosin ± SEM 
4 days pre-treatment 29.1 ±1.76 23.3 ± 1.85 22.2 ± 1.76 
2 days pre-treatment 32.4 ± 1.76 30.6 ±1.85 33.4 ± 1.76 
12 hours post-treatment 38.2 ± 1.76 38.4 ±1.96 39.1 ± 1.76 
36 hours post-treatment 31.5 ±1.76 32.5 ± 1.85 30.4 ± 1.76 
60 hours post-treatment 45.5 ± 1.76 46.1 ± 1.96 41.8 ± 1.76 
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Table 5. Percent iodination as measured using opsonized zymosan (iodination assay) reported 
as least-squares means and standard error; evaluates myeloperoxidase/hydrogen 
peroxide/halide system of neutrophils. Neutrophils were collected 4 and 2 days before and 
12, 36 and 60 hours after treatment with danofloxacin, tihnicosin or saline. 
Control ± SEM Danofloxacin ± SEM Tilmicosin ± SEM 
4 days pre-treatment 40.8 ±4.75 36.9 ± 5.00 32.1 ±4.75 
2 days pre-treatment 32.8 ±1.74 33.8 ±1.92 33.3 ± 1.82 
12 hours post-treatment 25.5 ±2.10 30.1 ±2.21 31.4±2.I0 
36 hours post-tteatment 23.3 ±1.81 24.3 ± 1.91 25.0 ± 1.81 
60 hours post-treatment 23.0 ±1.99 24.2 ± 2.09 20.7 ± 2.07 
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Table 6. Optical density of neutrophils incubated with Cytochrome C and opsonized 
zymosan (Cytochrome C reduction assay) reported as least-squares means and standard error. 
Neutrophils were collected 4 and 2 days before and 12, 36 and 60 hours after treatment with 
danofloxacin, tilmicosin or saline. 
Control ± SEM Danofloxacin ± SEM Tilmicosin ± SEM 
4 days pre-treatment 0.46 ± 0.037 0.45 ±0.041 0.39 ± 0.037 
2 days pre-treatment 0.68 ± 0.037 0.66 ± 0.041 0.61 ±0.037 
12 hours post-treatment 0.44 ±0.037 0.53 ± 0.039 0.49 ± 0.037 
36 hours post-treatment 0.44 ±0.037 0.45 ± 0.039 0.48 ± 0.037 
60 hours post-treatment 0.53 ±0.037" 0.57 ±0.039" 0.41 ±0.038 
"p=0.02, p=0.005; level of statistical significance for the difference bet\veen means with the 
same superscript. 
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Table 7. Percent lysis of radiolabeled chicken erythrocytes (cRBC) without anti-cRBC 
antibody reported as least-squares means and standard error. Neutrophils were collected 4 
and 2 days before and 12, 36 and 60 hours after treatment with danofloxacin, tilmicosin or 
saline. 
Control ± SEM Danofloxacin ± SEM Tilmicosin ± SEM 
4 days pre-treatment 4.02 ±1.30 3.77 ±2.06 1.85 ±0.43 
2 days pre-treatment 3.21 ± 1.09 2.01 ± 1.48 0.95 ±0.39 
12 hours post-treatment 1.12 ±0.66 2.83 ±1.53 0.17±0.1l 
36 hours post-treatment 4.58 ± 1.90 4.59 ±2.62 3.28 ±2.17 
60 hours post-treatment 2.18 ±1.52 6.21 ±3.96 5.99 ±3.77 
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Table 8. Percent lysis of radiolabeled chicken erythrocytes (cRBC) in the presence of anti-
cRBC antibody reported as least-squares means and standard error. Neutrophils were 
collected 4 and 2 days before and 12, 36 and 60 hours after treatment with danofloxacin, 
tilmicosin or saline. 
Control ± SEM Danofloxacin ± SEM Tilmicosin ± SEM 
4 days pre-treatment 40.86 ±3.59 41.03 ±3.79 33.46 ± 3.59 
2 days pre-treatment 31.80 ±3.59 28.94 ± 3.79 27.88 ± 3.59 
12 hours post-treatment 19.12 ±3.59 27.26 ± 3.79 21.01 ±3.59 
36 hours post-treatment 28.40 ±3.59 31.34 ±3.79 33.16 ±3.59 
60 hours post-treatment 25.09 ±3.59 33.08 ± 3.79 27.48 ± 3.59 
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Table 9. Total leukocyte count from peripheral blood reported as least-squares means and 
standard error. Blood samples were collected 4 and 2 days before and 12, 36 and 60 hours 
aiter treatment with danofloxacin, tilmicosin or saline. 
Cootrol ± SEM Danofloxacin ± SEM Tiimicosin ± SEM 
4 days pre-treatment 7.07 ±0.62 7.72 ± 0.65 7.46 ± 0.62 
2 days pre-treatment 8.67 ± 0.62 8.94 ± 0.65 9.02 ± 0.62 
12 hours post-treatment 7.78 ±0.62'' 8.63 ±0.65" 11.39 ±0.62'" 
36 hours post-treatment 6.83 ±0.62" 7.63 ±0.65 8.81 ±0.62' 
60 hours post-treatment 7.81 ±0.62 8.52 ±0.65 8.97 ±0.62 
means with the same superscript. 
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Table 10. Total neutrophil count from peripheral blood reported as least-squares means and 
standard error. Blood samples were collected 4 and 2 days before and 12, 36 and 60 hours 
after treatment with danofloxacin, tilmicosin or saline. 
Control ± SEM Danofloxacin ± SEM Tilmicosin ± SEM 
4 days pre-treatment 3.08 ±0.31 3.37 ±0.53 2.72 ± 0.50 
2 days pre-treatment 3.05 ±0.31 3.37 ±0.53 3.08 ± 0.50 
12 hours post-treatment 3.63 ±0.31" 4.57 ±0.53" 6.65 ± 0.50" " 
36 hours post-treatment 2.86 ±0.31 3.23 ± 0.53 3.4 ± 0.50 
60 hours post-treatment 3.04 ±0.31 3.46 ± 0.53 3.15 ±0.50 
''p=0.0001, p=0.006; level of statistical significance for the difference benveen means with 
the same superscript. 
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Table 11. Hemoglobin concentration from peripheral blood reported as least-squares means 
and standard error. Blood samples were collected 4 and 2 days before and 12,36 and 60 
hours after treatment with danofloxacin, tilmicosin or saline. 
Control ± SEM Danoflo.\acin ± SEM Tilmicosin ± SEM 
4 days pre-treatment 13.07 ±0.26 12.69 ± 0.28 12.79 ± 0.26 
2 days pre-treatment 12.46 ±0.26 12.36 ±0.28 12.56 ±0.26 
12 hours post-treatment 12.38 ±0.26" 11.59 ± 0.28 12.43 ±0.26" 
36 hours post-treatment 12.35 ± 0.26 11.99 ±0.28 12.25 ±0.26 
60 hours post-treatment 12.12 ±0.26 11.67 ±0.28 11.80 ±0.26 
^p=0.042, ''p=0.031; level of statistical significance for the difference between means with the 
same superscript. 
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Table 12. Hematocrit of peripheral blood reported as least-squares means and standard error. 
Blood samples were collected 4 and 2 days before and 12, 36 and 60 hours after treatment 
with danofloxacin, tilmicosin or saline. 
Control ± SEM Danofloxacin ± SEM Tilmicosin ± SEM 
4 days pre-treatment 36.65 ±0.72 34.64 ±0.76 34.63 ±0.72 
2 days pre-treatment 34.09 ±0.72 33.64 ±0.76 34.16 ±0.72 
12 hours post-treatment 34.13 ±0.72" 31.77 ± 0.76 33.98 ±0.72" 
36 hours post-treatment 33.67 ±0.72 33.03 ±0.76 33.62 ±0.72 
60 hours post-treatment 33.1 ±0.72 31.86 ±0.76 32.30 ±0.72 
='p=0.026, ''p=0.037; leve of statistical signi Icance for the difference benveen means with tl 
same superscript. 
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Table 13. Total platelet count reported as least-squares means and standard error. Blood 
samples were collected 4 and 2 days before and 12, 36 and 60 hours after treatment with 
danofloxacin, tilmicosin or saline. 
Control ± SEM Danofloxacin ± SEM Tilmicosin ± SEM 
4 days pre-treatment 848.7 ± 64. I*-" 477.4 + 67.5^ 582.9 ±64.1" 
2 days pre-treatment 711.0 ±64.1' 545.4 ± 67.5 476.7 ±64.1' 
12 hours post-treatment 422.5 ±64.1 449.3 ±67.5 365.7 ±64.1 
36 hours post-treatment 479.8 ±64.1 433.3 ± 67.5 387.5 ±64.1 
60 hours post-treatment 518.2 ±64.1 422.9 ±67.5 423.8 ±64.1 
®p=0.000l, p=0.004, '^p=0.011; level of statistical significance for the difference between 
means with the same superscript. 
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Figure Legends 
Figure 1. The distance neutrophils migrated under agarose in mm" (neutrophil random 
migration assay), reported as least square means with standard error bars. Neutrophils were 
collected 4 and 2 days before and 12,36 and 60 hours after treatment with danofloxacin, 
tilmicosin or saline. 
Figure 2. Neutrophil chemotaxis reported as chemotactic index with 95% confidence 
intervals. Neutrophils were collected 4 and 2 days before and 12, 36 and 60 hours after 
treatment with danofloxacin, tilmicosin or saline. 
Figure 3. Percent radiolabeled S. aureus ingested by neutrophils {Staphylococcus ingestion 
assay) reported as least-squares means with standard error bars. Neutrophils were collected 4 
and 2 days before and 12, 36 and 60 hours after treatment with danofloxacin, tilmicosin or 
saline. 
Figure 4. Percent iodination as measured using opsonized zymosan (iodination assay) 
reported as least-squares means with standard error bars; evaluates 
rayeloperoxidase/hydrogen peroxide/halide system of neutrophils. Neutrophils were collected 
4 and 2 days before and 12, 36 and 60 hours after treatment with danofloxacin, tilmicosin or 
saline. 
Figure 5. Optical density of neutrophils incubated with Cytochrome C and opsonized 
zymosan (Cytochrome C reduction assay) reported as least-squares means with standard 
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error bars. Neutrophils were collected 4 and 2 days before and 12, 36 and 60 hours after 
treatment with danofloxacin, tilmicosin or saline. Statistically significant differences 
between means are indicated by a (p=0.02) and b (p=0.005). 
Figure 6. Percent lysis of radiolabeled chicken erythrocytes (cRBC) without anti-cRBC 
antibody reported as least-squares means with standard error bars. Neutrophils were collected 
4 and 2 days before and 12, 36 and 60 hours after treatment with danofloxacin, tilmicosin or 
saline. 
Figure 7. Percent lysis of radiolabeled chicken erythrocytes (cRBC) in the presence of anti-
cRBC antibody reported as least-squares means with standard error bars. Neutrophils were 
collected 4 and 2 days before and 12, 36 and 60 hours after treatment with danofloxacin, 
tilmicosin or saline. 
Figure 8. Total leukocyte count from peripheral blood reported as least-squares means with 
standard error bars. Blood samples were collected 4 and 2 days before and 12, 36 and 60 
hours after treatment with danofloxacin, tilmicosin or saline. 
Figure 9. Total neutrophil count from peripheral blood reported as least-squares means with 
standard error bars. Blood samples were collected 4 and 2 days before and 12,36 and 60 
hours after treatment with danofloxacin, tilmicosin or saline. 
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Figure 10. Hemoglobin concentration from peripheral blood reported as least-squares means 
with standard error bars. Blood samples were collected 4 and 2 days before and 12, 36 and 60 
hours after treatment with danofloxacin, tihnicosin or saline. 
Figure 11. Hematocrit of peripheral blood reported as least-squares means with standard 
error bars. Blood samples were collected 4 and 2 days before and 12, 36 and 60 hours after 
treatment with danofloxacin, tilmicosin or saline. 
Figure 12. Total platelet count reported as least-squares means with standard error bars. 
Blood samples were collected 4 and 2 days before and 12, 36 and 60 hours after treatment 
with danofloxacin, tilmicosin or saline. 
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CHAPTER 3. DEVELOPMENT OF AN INDUCED PASTEURELLA PNEUMONIA 
MODEL IN WEANED BEEF CALVES 
A paper submitted to the American Journal of Veterinary Research 
Virginia R. Faji, Michael D. Apley, James A. Roth, Kim A. Brogden, Dagmar E. Frank, 
Terry L. Skogerboe, Valerie Karle, Arthur Dayton 
Abstract 
Objective 
To develop a model of inducing pneumonic pasteurellosis in weaned, pre-conditioned beef 
calves that consistently produced rectal temperatures of at least 40°C 24 hours after bacterial 
challenge, a clinical score of >1, and measurable lung consolidation; to verify a method of 
collecting continuous body temperatures via telemetry; and to evaluate the functional ability 
of lung neutrophils during pneumonia. 
Animals 
12 weaned Angus-cross beef heifers (172-200 kg) from a single ranch with no recent history 
of respiratory disease or antimicrobial therapy. 
Procedure 
Approximately 6 x 10^ CFU of a log-phase culture of Pasteurella haemolytica were instilled 
intratracheally (via needle puncture) or intrabronchially (via bronchoalveolar lavage 
catheter). Core body temperatures were continuously monitored via radiotransmitters placed 
intravaginaily in the animals. Bronchoalveolar lavages were performed to collect lung 
neutrophils for evaluation in neutrophil ftmction assays. 
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Results 
All 8 animals exhibited the desired clinical score and 7 of the 8 the desired rectal temperature 
at 24 hours after inoculation. Transmitters remained in place for the entire study period. 
Performance of the lung neutrophil assays was unpredictable; few viable cells could be 
isolated. Lung consolidation averaged 17.3%, and was histopathologically consistent with 
pneumonic pasteurellosis. 
Conclusions 
This model represents a consistent method of producing Pasteurella pneumonia in weaned, 
pre-conditioned beef calves with the desired clinical case characteristics. Lung lavage 
neutrophil function could not be evaluated, but lung consolidation and body temperature 
were evaluated with ease. 
Clinical Relevance 
The model can be used for trials of pharmacotherapeutics to evaluate differences in lung 
consolidation, core body temperature, and clinical response in weaned pre-conditioned beef 
calves. 
Introduction 
Bovine respiratory disease caused by Pasteurella haemolytica continues to be one 
of the most important diseases in the cattle industry worldwide.^ To study 
phannacotherapeutic or immunologic interventions, many methods of inducing experimental 
pneumonic pasteurellosis have been utilized. This disease has been induced in cattle by 
instilling fresh live cultures of Pasteurella haemolytica into the trachea,^ into main stem 
bronchi using an endoscope,^ into the thoracic cavity percutaneously (transthoracic),'* or by 
aerosol nasally.^ Workers have also used protocols that include physical stressors such as 
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exercise® or cold water' and chemical stressors such as acetic acid in the trachea.® Many of 
these models were developed in neonatal dairy calves. In contrast, we were interested in 
developing a model of inducing pneumonic pasteurellosis in older, weaned, pre-conditioned 
beef calves without the use of invasive methods such as transthoracic needle puncture and 
without the necessity of determining P. haemolytica antibody titres. In addition, we were 
interested in developing a model that could be evaluated with a simple clinical scoring 
scheme rather than a complicated method requiring evaluating multiple clinical parameters. 
The use of easily characterized clinical parameters for identification of diseased 
animals is desirable. Methods for clinical evaluation of calves with bovine pneumonic 
pasteurellosis have been described that allow for the scoring of animals on a scale from 0 to 
4, 0 being normal, and 4 being moribund.' In a typical clinical trial of an antimicrobial, 
animals are eligible for entry into the trial if they exhibit a clinical score of I, 2, or 3, i.e., 
ranging from noticeable depression with no apparent signs of weakness to severe depression 
accompanied by signs of weakness such as altered gait. (Animals are not eligible if they 
show signs of disease attributable to organ systems other than the respiratory tract.) A rectal 
temperature of40°C is commonly recommended as a minimal criterion for inclusion.' 
An additional requirement in some models is negative or low titres to P. haemolytica. 
A model capable of inducing disease without requiring expensive or time-consuming 
serology in calves with an unknown history of prior exposure was needed. This would allow 
increased availability of cattle for experimental pharmaceutical trials. 
Accurate, impartial methods for evaluating disease severity are needed to evaluate 
treatment response. Many studies have recorded rectal temperatures periodically over the 
course of mfection and treatment. However, it is impractical to measure rectal temperatures 
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more than a few times a day. The use of remote body temperature devices allows close 
monitoring of changes in body temperature over time. Body temperature radiotelemetry has 
been utiUzed in multiple species, and studies in cattle have focused on normal body 
temperature responses to environmental temperature'" " or to estrous cycles'". A few reports 
of the use of radiotelemetry in cattle disease models have also been published, including 
coliform mastitis.'^ To our knowledge, radiotelemetry of body temperature has not been 
reported in bovine respiratory disease models. By evaluating body temperature response on 
an essentially continuous basis during a disease episode and its treatment, differences 
between treatment groups may be evaluated. 
The ability of antimicrobials to modulate the inflammatory process has become an 
important area of research. In human medicine, the antiinflammatory benefits of many 
antimicrobials have been reviewed.'"*'^ The use of these types of compounds to treat bovine 
pneumonic pasteurellosis is very attractive, since the inflammation and resultant tissue 
damage often contributes to the clinical signs of bovine pneumonic pasteurellosis.'^'^ It has 
been hypothesized that antimicrobials that modulate the neutrophil response may decrease 
pulmonary damage following infection with P. haemolytica. For example, tilmicosin was 
reported to induce apoptosis of lung neutrophils and therefore to potentially modulate 
inflammation." To characterize the response of neutrophils as well as attempting to correlate 
neutrophil activity with clinical response variables, a reliable method of isolating lung 
neutrophils was needed. In addition, the assays performed needed to be validated for lung 
neutrophils as they had previously only been performed in our laboratory on neutrophils 
isolated from blood. 
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The goals of the study were several. The first goal was to develop a method that 
consistently produced rectal temperatures of at least 40°C at the time of treatment, with a 
clinical score of 1 or greater, and measurable lung consolidation in weaned, pre-conditioned 
beef calves with unknown history of exposure to P. haemolytica. Other objectives included 
the refinement of a method of continuously monitoring body temperature using telemetry, 
and the evaluation of a method of collecting lung neutrophils and measuring their functional 
capabilities. 
Materials and Methods 
The experimental protocol was approved by the Iowa State University Committee on 
Animal Care. 
Animals 
Angus-cross heifers weighing an average of 181.3 kg (SD=19.0) on arrival, 
approximately 6 months of age, were purchased as a group from a single herd in Nebraska 
and shipped to allow 14 days of acclimation prior to the start of the study. Calves were pre­
conditioned prior to their arrival at the study site with modified live viral respiratory 
vaccines; no Pasteurella vaccine was administered. Animals that exhibited any clinical signs 
of disease before P. haemolytica inoculation were removed from eligibility for the study and 
treated as appropriate. 
Animals were housed outdoors in concrete-floored pens, one pen per group, with 
open fi-ont sheds as shelter. Area provided per animal was approximately 35 m^. They were 
fed free choice hay and a grain supplement balanced to allow weight gain of approximately 
1.5 Ibs/head/day. Water was provided ad libitum. The grain supplement contained monensin 
sodium at a rate of approximately 150 mg/head/day. 
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Twelve animals weighing 172-200 kg were selected for the P. haemolytica 
inoculation procedure as follows: A random number from a umform distribution on the 
interval (0,1) was assigned to each eligible animal. The animals were sorted by this random 
number, and the first 20 were assigned to the procedure. The rest were assigned to be 
alternate animals in the order in which they were sorted. 
Clinical Case Criteria 
The clinical scoring system used has been previously described.' Briefly, a score of 
0 is a normal animal, 1 is noticeable depression without apparent signs of weakness, 2 is 
marked depression with moderate signs of weakness without significantly altered gait, 3 is 
severe depression with signs of weakness such as significantly altered gait, and 4 is moribund 
and unable to rise. Clinical scores were determined just prior to inoculation with P. 
haemolytica, and at 6,24,48, 72 and 96 hours after inoculation. The 24-hour time point 
corresponds to the point at which treatment would be administered in a therapeutic trial. 
The successful induction of respiratory disease was defined as a rectal temperature of 
> 40°C and a clinical score of I or greater, meaning noticeable to severe depression with or 
without signs of weakness. Animals that displayed a clinical score of 4 (moribund, unable to 
rise) were immediately evaluated for euthanasia and were not eligible for the study. 
Bacterial Challenge 
A frozen (-70®C) stock culture of Pasteurella haemolytica A1 strain LlOl isolated 
from a calf with pneumonia and then stored at -TO'C was used. After thawing, the culture 
was streaked on Trypticase Soy Agar plates containing 5% defibrinated sheep blood and 
incubated overnight at 37°C. The next morning, the growth was transferred to tryptose broth 
and incubated for 3 hours at ST'C on a magnetic stirrer. Then the broth culture was adjusted 
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spectrophotometrically to an approximate concentration of 1 x 10® colony forming units/ml. 
Concentrations of bacteria were verified after the inoculation procedure with standard plate 
counts by removing 1 ml of inoculum, performing 10-foId serial dilutions up to 1x10^, and 
plating 0.1 ml of each dilution on 5 blood agar plates. After incubating overnight at 37°C, 
the number of colony forming units was counted and averaged over the 5 plates. 
For the first group of 4 calves (Group I), 15 cc of culture fluid was administered 
transtracheally using a 14-gauge needle. For the second group of 4 calves (Group 2), 20 cc 
of cultiu-e fluid was administered transtracheally. For the third group of 4 calves (Group 3), 
20 cc of culture fluid was administered to each calf through an equine bronchoalveolar 
lavage catheter." Briefly, the catheter was passed through the nares into the trachea as far as 
possible into a caudal lung lobe, then withdrawn approximately 20 cm so that inoculation 
would occur close to the level of the tracheal bifurcation. Culture fluid was placed in the 
catheter, followed by approximately 180 ml of air pushed in rapidly with a 60 cc syringe. 
Radiotelemetry 
Temperatures were monitored using VHF transmitters'' encased in paraffin. The 
transmitters broadcast signals in the range of 150.236-151.936 MHz. An antennae and 
receiver*^ were connected to a personal computer, where the signals were converted to digital 
pulses by a controller card in a personal computer.'' The digital pulses were then translated 
by proprietary software,® using calibration charts provided by the company. The inter-pulse 
interval was proportional to body temperature. The temperatures were automatically stored 
on the computer hard drive. An uninterruptible power supply was used to prevent data loss 
during power surges/ The antenna was placed on a fence post in the pen, allowing for a 
maximum of approximately 30 meters firom the antenna to any location in the pen. 
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The transmitters were implanted at least 3 days prior to inoculation of P. haemolytica 
as follows: A low caudal epidural was performed using 3 cc of lidocaine,® and then the 
transmitter was lubricated with sterile jelly^ and placed intravaginally cranial to the vestibular 
muscle to ensure retention. The software was programmed to read body temperature every 5 
minutes. 
Bronchoalveolar Lavage 
At 24 and 48 hours after inoculation with P. haemolytica, the calves in Groups 2 and 
3 were restrained in a squeeze chute, and the head was anchored nose up with two halters. A 
bronchoalveolar lavage catheter,® disinfected between animals with dilute chlorhexidine,' was 
passed through the nasal passages into the trachea, advanced as far as physically possible and 
wedged into a terminal bronchus. An aliquot of 60 ml of sterile phosphate buffered saline 
was instilled through in the BAL tube and as much as possible was aspirated back into the 
syringe. This was performed 2 more times. For each sample, approximately 1 ml was placed 
in a sterile 10 ml tube for bacterial culture,^ 1 ml in a EDTA-containing tube for cytology,^ 
and the rest in sterile glass tubes for neutrophil isolation. 
Samples submitted for cytology were analyzed in an automated cell counter,'' and the 
following cells were counted: leukocytes, erythrocytes, neutrophils, lymphocytes, 
monocytes, eosinophils, basophils, and platelets. Hemoglobin was measured, samples were 
evaluated visually for transparency and color, and pH and total protein were measured by 
refractometry. 
Neutrophil Isolation 
Bronchoalveolar lavage samples were centrifuged at 200 x g for 10 minutes and the 
supernatant discarded. The cell pellets were resuspended in 10 ml of phosphate buffered 
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saline and counted. Samples were suspended with Hanks balanced salt solution to a 
concentration of 5 x 10^ cells/ml for use in the neutrophil assays. Further purification was 
attempted with some of the samples by centrifiiging over 1.077 specific gravity ficoll-
hypaque.' 
Neutrophil Assays 
These assays have been previously described*"'"^. Random migration under agarose 
was performed using a modification of the method of Roth and Kaeberle. Six holes were 
punched in agar containing Minimum Essential Medium with Earles salts containing 0.8% 
agarose, 10% fetal calf serum, and 1% antibiotic-antimycotic solution. Neutrophils were 
added to the wells, two samples per animal, and the plates were incubated at 39°C in 5% 
COi, for 18 hours. Plates were then flooded with 8% glutaraldehyde for at least one hour. 
After removing the agar, plates were flooded with 0.1% crystal violet for at least 10 minutes 
in order to stain the cells adhering to the plates. Plates were read on an inverted microscope 
using the lOx planar objective by measuring the distance in millimeters radially from the 
center of the neutrophil well to the farthest point of random migration. 
The cytochrome C reduction assay was performed by incubating opsonized 
2:ymosan with cytochrome C and neutrophils in Hank's balanced salt solution (HBSS), and 
the optical density of the supernatant at 550 nm was determined. Background values were 
measured by replacing zymosan with HBSS, and then subtracted from the results obtained 
with zymosan. 
For the iodination assay, opsonized zymosan, Nal, and '"l-Na were pre-warmed in 
Earle's Balanced Salt Solution at 39'C, and neutrophils were added. The tubes were tumbled 
for 20 minutes at 39°C, the reaction stopped with cold 10% trichoroacetic acid, and 
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centrifuged for 10 minutes at 1000 g. After discarding the supernatant, the wash was 
repeated, and radioactivity in the neutrophils was measured in a gamma counter"^ and 
reported as counts per minute (CPM). Results were calculated as follows: 
fCPM for experimental sampled - TCPM for blank) x (40 nmol Nal) x ( l .Ox 10 '  neut rophi l s )  x 60 mins 
(CPM for standard sample) (2.5 x 10° neutrophils) 20 mins 
For the S. aureus ingestion assay, heat-killed '^I-labeled S. aureus, anti-5. aureus 
antiserum, and 2,5 x 10® neutrophils were incubated in Earle's Balanced Salt Solution at 
39°C for 10 minutes. Lysostaphin was added, and the tubes incubated for 30 minutes at 
39°C. The reaction was stopped with PBS, and the tubes centrifuged at 4C for 10 minutes at 
1250 g. After removing the supernatant and repeating the wash procedure, radioactivity 
associated with the neutrophils was measured in a gamma counter in counts/minute (CPM). 
Results were calculated as follows: 
Percent ingestion = (CPM in reaction tube - CPM in background tube^ x 100 
(CPM in standard tube - CPM in background tube) 
Chemotaxis was evaluated under agarose, using zymosan activated bovine serum as 
the chemoattractant. After measuring the distance migrated toward Medium 199 (random 
migration) and the distance migrated toward the activated serum (chemotaxis), a chemotaxis 
index was generated by dividing chemotaxis by random migration. 
The antibody-dependent and antibody-independent cell-mediated cytotoxicity assay 
was performed as follows: radiolabeled (^'Cr) chicken erythrocytes (cRBC's) in Medium 199 
were incubated for 2 hours at 37®C in 5% CO2 with neutrophils in the presence or absence of 
anti-cRBC antibody. Triton X, neutrophil only, and antibody controls were included. Each 
animal was represented in quadruplicate. Supernatant was filtered out using a Skatron 
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harvester apparatus. Samples were then placed in a gamma counter and read for 2 minutes. 
Results were expressed as a percentage of lysis and calculated as follows: 
% lysis = (Counts per minute in reaction tubeVfCounts per minute in background tube) x 100 
(Counts per minute in standard tube)-(Counts per minute in background tube) 
Lung Lesions 
Inoculated heifers from Group 2 and 3 were euthanatized with an overdose of 
barbiturate." At necropsy, lungs were removed from calves, and the percentage of 
consolidation of each lobe was visually estimated. Estimates were to the nearest 10%, except 
that lobes with less than 10% but greater than 0% consolidation were estimated as 5%. 
Previously unpublished data° derived from bovine lungs obtained from a slaughter house 
were used to construct the following formula to calculate total lung consolidation: 
Total percent lung consolidation = (0.053*cranial segment of left cranial lobe %) + 
(0.049*caudal segment of left cranial lobe %) + (0.319*left caudal lobe %) + 
(0.043*accessory lobe %) + (0.352*right caudal lobe %) + (0.061 •right middle lobe %) + 
(0.060*caudal segment of right cranial lobe %) + (0.063*cranial segment of right cranial lobe 
%) 
Areas of consolidation were sampled for histopathology and bacterial culture. 
Statistical Analysis 
The transmitters were re-calibrated after study completion by the supplier, and 
correction factors were calculated for each transmitter to account for drift in temperature over 
the battery life of the transmitters. Because the transmitters are subject to interference, a 
procedure was established to remove outliers that did not fit with the surrounding data and 
that were therefore considered anomalous. An overall mean and the standard deviation of the 
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temperatures over the entire period was calculated. If an observation was greater than 3 
standard deviations from the overall mean, the value was removed from the data set. In 
addition, observations of < 37.5°C or > 42.5°C were considered outside of the normal 
physiological range and were removed from the data set. The data were smoothed such that 
a running average of 10 observations was used to display individual calf temperatures. 
The average core body temperature pre-challenge (in °C) for each animal minus 1°C 
was used as a baseline for that animal. The area under the curve above the baseline for each 
animal was calculated for each 12-hour interval pre- and post-challenge, and geometric 
means of the areas under the curve were calculated for Groups 2 and 3. If there were fewer 
than 10 observations for a given time period, the area under the curve calculation was 
dropped from the analysis. The arithmetic mean temperature was also calculated for each 
animal within each 12-hour interval. 
Descriptive statistics were calculated for each of the neutrophil assays, for the 
cytology data, and for the lung consolidation data. A general linear mixed model was used to 
compare consolidation in the left and right sides of the lungs. 
Results 
Group 1 calves, to which the challenge inoculum was administered transtracheally at 
a dose of 15 ml/calf, returned to clinical scores of 0 (no depression) by 48 hours after 
inoculation, and these animals were not necropsied for lung evaluation. Animals in Group 1 
did exhibit a peak in core temperature as measured by the transmitters, but the temperatures 
were below 40°C by 36 hours after challenge. 
The dose of inoculum was increased to 20 ml/calf transtracheally for Group 2. The 
inoculation procedure was then altered as described above by using a catheter intranasally to 
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administer the bacterial culture for Group 3. This method was selected due to ease and speed 
of inoculation, and to attempt to place more inoculum into the bronchi rather than the 
trachea. At 24 hours, all 8 calves (Groups 2 and 3) that received 20 mi of inoculum exhibited 
a clinical score of 1 or greater (Figures 1 and 2), and 7 of the 8 calves had a rectal 
temperature of 40°C or greater. 
The radiotransmitters remained in place throughout the experiment (a week or 
longer). No surgical fixation or other device to prevent expulsion was required. After "no 
signals" and outliers (data points that appeared to be physiologically improbable) were 
removed, an average of 361 data points remained for analysis for each calf in Group 2, and 
1051 data points for Group 3. 
Bronchoalveolar lavages were performed on Group 2 and 3 calves at 24 and 48 hours 
after inoculation. For 7 of the 8 calves sampled, most of the 180 ml of solution instilled into 
the lungs was recovered. Cytology results are shown in Table 1; actual neutrophil counts 
were only obtained on the 24-hour samples. The 48-hour lavages contained very low 
numbers of neutrophils. Bacterial culture of all the samples from 24 and 48 hours post-
inoculation yielded no growth of Pasteurella haemolytica, although low to moderate 
numbers of contaminants such as Streptomyces sp., Pseudomonas sp. and Staphylococcus 
epidermidis were isolated firom all but 2 animals. 
Neutrophils were isolated from the lavage fluid from 3 of the 8 calves at 24 hours and 
from 5 of the 8 calves at 48 hours after challenge. From the 3 calves at 24 hours, 2 of the 3 
samples contained mostly mononuclear cells rather than neutrophils. The neutrophils tended 
to clump and were diflicult to isolate even after filtering through a density gradient.' There 
were not enough neutrophils from the 8 successful bronchoalveolar lavage samples to 
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perform all of the assays, so only certain assays were performed on each sample (see Table 2 
for number of assays performed). Even with sufficient sample, the neutrophils performed 
poorly in the majority of the assays (data not shown). For example, the neutrophil 
chemotaxis assays and the random migration assays produced no results, since no neutrophils 
migrated out of the wells. 
An estimation of percent consolidation by lung lobe was made visually and by 
palpation, and the mean percentage by lobe is displayed in Table 3, along with the proportion 
of the total consolidation contributed by each lobe. Mean total lung consolidation was 
17.3%, with a range of 5.0-37.5%. The left lobes contributed 12.1% to the total, and the right 
lobes contributed 75.1%, which is statistically significant. All calves had some degree of 
consolidation in the accessory lobe. Grossly, the lung lesions resembled fibrinous 
bronchopneumonia. Microscopic examination of consolidated areas revealed severe 
subacute fibrinosuppurative and necrotizing pleuropneumonia consistent with pneumonic 
pasteurellosis. Bacterial culture of consolidated areas resulted in pure cultures of P. 
haemolytica in 7 of the 8 samples, and a mixed culture of P. haemolytica and P. multocida in 
1 sample. 
Discussion 
Eight calves with unknown prior exposure to P. haemolytica inoculated 
intratracheally or intrabronchially with approximately 2.0 x lO' cfu of P. haemolytica 
exhibited a clinical score of > 1, and 7 of the 8 developed rectal temperatures of > 40'C at 24 
hours post-inoculation. The resultant proportion of animals exhibiting the criteria established 
for entrance into a respiratory disease pharmacotherapeutic trial suggests this inoculation 
procedure would be acceptable for inducing disease in large numbers of animals. When 
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using relatively expensive animals such as weaned beef calves, this is an important 
consideration in choosing a model. The intrabronchial method of inoculation was much 
easier and faster to perform than the intratracheal in addition to being less invasive than 
transthoracic. The considerable skin and fat in the throat latch region in these calves made 
isolating the trachea for injection of the inoculum cumbersome and difficult. 
Body temperature radiotransmitters were used successfully and remained in place for 
the duration of the disease episode, without the use of surgical or physical retention devices. 
This makes the use of heifers attractive for these types of trials, since surgical implantation of 
the transmitters is required in steers. The methods used for the descriptive statistics are 
attractive for comparing tteatment modalities in disease episodes. Calculating the area under 
the curve using a baseline for each individual animal removes the variability of normal core 
temperatures among animals and allows for statistical comparisons among time periods. The 
use of average temperatures instead of area under the curve would not characterize the 
fluctuations in temperature as well, and high peaks or troughs would tend to be 
underrepresented. Additionally, using the area under the curve helps remove the variability 
in temperatiu-e among animals, since the absolute temperature of the animal is not part of the 
equation but rather the relative change in temperatiu-e around baseline. 
The cytology of bronchoalveolar lavages collected resembled the cytology of normal 
lungs, rather than pneumonic lungs. The samples contained an average of 327 leukocytes/(al 
and 295 leukocytes/nl at 24 and 48 hours respectively, as compared to 1312-1615 
leukocytes/^1 in one study of pneumonic calves.'^ The percentage of neutrophils in our study 
more closely resembled that of Paulson et al. for Group 2 but not for Group 3. In Group 3, 
neutrophils were 16% of the leukocytes, similar to pre-challenge in the previously mentioned 
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Study where neutrophils were 12% of the total leukocytes. One possible explanation for the 
difference in our study was the collection procedure. The bronchoalveolar lavage catheter 
was lodged in a caudal lung lobe before instilling the collection medium. If it lodged in the 
left caudal lobe, where gross exam at necropsy revealed a mean of 2% consolidation, 
neutrophil exudation and harvest would be expected to be minimal. This explanation is 
consistent with the inability to isolate P. haemolytica on bacterial culture. In addition, this 
explanation fits with the lung consolidation data, which suggest that more inoculum reached 
the right side than the left side of the lung, since 75% of the total consolidation was 
attributable to the right lung lobes. 
The results from the assays on the bronchoalveolar lavage neutrophils were not 
consistent with findings from the same laboratory using the same assays on blood 
neutrophils. For example, in a study revealing reduced neutrophil function in cattle 
persistently infected with bovine viral diarrhea virus, even in the low performing groups, 
Cytochrome C reduction was 0.74 (vs. 0.16 in our study), iodination was 25 (vs. 0.25-5.65 in 
our study), and antibody-dependent cytotoxicity was 48% (vs. 13.5-22.4 in our study).^ 
Neutrophils failed to migrate in our study in the random migration and chemotaxis assays, 
suggesting non-viable cells. The low performance of the neutrophils in the function assays 
along with the low yield of neutrophils from the bronchoalveolar lavages suggest that lung 
neutrophils are not a good choice for evaluating response to infection, antimicrobial therapy 
or both. This is in contrast to the findings of Chin et al.,'' who were able to isolate 
neutrophils from the lungs of infected calves. However, the assays they selected did not 
necessarily characterize the viability of the neutrophils. Viable neutrophils are required to 
perform in the assays used in the present study to evaluate migration, phagocytosis and 
82 
oxidative functions. Circulating neutrophils are the pool from which cells are recruited to 
sites of infection, so the collection of neutrophils from the blood is an attractive alternative. 
In addition, by collecting peripheral blood neutrophils, potential effects of the P. haemolytica 
itself on neutrophils in the lungs are minimized, since P. haemolytica will affect neutrophils 
by inducing apoptosis,*^ causing cell membrane damage,"' and decreasing 
chemiluminescence (a measure of the respiratory burst used to produce oxygen radicals for 
bacterial killing)."® 
Gross and histologic examination of the lungs at necropsy revealed lesions consistent 
with naturally-occurring subacute pneumonic pasteurellosis, which concurred with the 
bacterial culture of the consolidated regions. The percentage lung consolidation found in the 
present study was consistent with previous work'''^° and provides another parameter for 
comparative purposes. In this study, it appeared that more inoculum reached the right lung 
lobes than the left, even in the calves inoculated intratracheally (p=0.000l). Interestingly, 
only I calf in the intrabronchial group had any lesions in the right cranial lobe, suggesting 
that the bronchoalveolar lavage catheter was in fact caudal to the tracheal bronchus. The 
resultant lesions, however, were consistent with the natural presentation of pneumonic 
pasteurellosis. 
In summary, we developed a simple method for reliably inducing Pasteurella 
pneumonia in weaned beef calves via bronchoalveolar lavage catheter. The inoculation 
resulted in greater than 80% of calves developing clinical scores of >1, rectal temperatures of 
>40°C, and measurable lung consolidation from which Pasteurella haemolytica could be 
cultured. It was determined that virtually continuous measurement of core body temperature 
and subsequent statistical analysis of the disease episode via temperature was possible in 
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heifer calves without surgical placement of transmitters. It was also determined that lung 
neutrophils collected via bronchoalveolar lavage were not sufficiently viable in this model 
for evaluation of pharmacotherapeutic interventions. 
Footnotes 
"Bivona, Inc., Gary, Indiana 
''Minimitter® Company, Sunriver, Oregon 
'^TR-2 receiver, Telonics, Mesa, Arizona 
''Gateway 386 personal computer, North Sioux City, South Dakota 
'DatacolS® Large Animal Monitoring Software, Minimitter Co., Sunriver, Oregon 
'American Power Conversion Corp., Back-UPS Pro 420, West Kingston, Rhode Island 
®Lidocaine 2% Injectable, Abbott Laboratories, North Chicago, Illinois. 
''K-Y® Lubricating Jelly, Johnson&Johnson Medical Inc., Arlington, Texas 
'Nolvasan® Solution, Fort Dodge Animal Health, Fort Dodge, Iowa 
Vacutainer, Becton Dickinson and Co., Franklin Lakes, New Jersey 
''Cell-Dyne 3500, Abbott Labs, Abbott Park, Illinois 
'Ficoll, Sigma, St. Louis, Missouri 
"Cobra Auto-Gamma, Packard Instrument Co., Downers Grove, Illinois 
"Beuthanasia®-D Special, Schering-Plough Animal Health, Union, New Jersey 
"Personal communication, Terry Skogerboe, Pfizer Animal Health, 1998 
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Figure Legends 
Figure 1. Clinical scores observed for Group 2 calves (n=4) after inoculation (scores are on a 
scale from 0-4, with 0 being normal and 4 being moribund; see text for complete 
explanation). 
Figure 2. Clinical scores observed for Group 3 calves (n=4) after inoculation (scores are on a 
scale from 0-4, with 0 being normal and 4 being moribund; see text for complete 
explanation). 
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Table 1. Cytology results for bronchoalveolar lavage samples from heifer calves in Groups 2 
and 3 as measured at 24 and 48 hours after intrabronchial challenge with 20 cc of bacterial 
culture fluid containing approximately 1x10* colony forming units/ml of P. haemolytica. 
Total leukocyte 
count (xlO^/^iI) 
Neutrophil 
count (xlO^/jol) 
Percent 
neutrophils 
Group 2-24 hours 0.249 0.157 63.0% 
Group 2-48 hours 0.288 a 17.5%" 
Group 3-24 hours 0.404 0.063 16.0% 
Group 3-48 hours 0.301 a 33.0%" 
®Not counted 
"Visual estimate 
Table 2. Number of beef heifer calves for which lung neutrophil assays could be performed 
due to lack of neutrophils in the samples. Bronchoalveolar lavages were performed on 8 
calves at 24 and 48 hours after intrabronchial challenge with 20 cc of bacterial culture fluid 
containing approximately 1 xIO® colony forming units/ml of P. haemolytica. 
Neutrophil Assay 
Hours after S. aureus Cytochrome lodination AICC/ Chemotaxis Random 
inoculation ingestion C reduction ADCC migration 
24 3 3 3 3 3 3 
48 2 0 2 4 0 2 
Total 5/16 3/16 5/16 7/16 3/16 5/16 
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Table 3. Lung lobe consolidation as estimated visually and by palpation. Mean proportion 
of each lobe is calculated as is the mean proportion of the entire consolidation from that lobe 
using the formula described in the text. 
Lung lobe Mean proportion 
consolidated of 
designated lobe ± SD 
Mean proportion of 
entire lung consolidation 
±SD 
Left Cranial-cranial segment 0.13 ±0.23 0.028+0.053 
Left Cranial—caudal segment 0.33 ±0.45 0.069 ± 0.092 
Left Caudal 0.019 ±0.037 0.024 ± 0.046 
TOTAL LEFT SIDE 0.12 ±0.19* 
ACCESSORY 0.51 ±0.45 0.13 ±0.12 
Right Caudal 0.19 ±0.29 0.30 ±0.35 
Right Middle 0.70 ± 0.34 0.37 ±0.28 
Right Cranial 0.063 ±0.18 0.013 ±0.038 
Right Cranial/cranial segment 0.16 ±0.27 0.072 + 0.15 
TOTAL RIGHT SIDE 0.75 ±0.23* 
*p=0.0001 
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CHAPTER 4. THE EFFECTS OF DANOFLOXACIN AND TILMICOSIN ON 
NEUTROPHIL FUNCTION AND LUNG CONSOLIDATION IN BEEF CALVES WITH 
INDUCED PASTEURELLA PNEUMONIA 
A paper prepared for submission to the Journal of Veterinary Pharmacology and 
Therapeutics 
Virginia R. Fajt, Michael D. Apley, James A. Roth, Dagmar E. Frank, Kim A. Brogden, 
Terry L. Skogerboe, Valerie K. Karle, Arthur D. Dayton 
Abstract 
Pasteurella pneumonia was induced in weaned beef heifer calves, approximately 6 months of 
age. Calves were treated at 20 hours after challenge with therapeutic doses of danofloxacin 
or tilmicosin. Peripheral blood neutrophils were collected at 3, 24 and 48 hours after 
treatment. The ex vivo effects on neutrophil fimction, neutrophil apoptosis, and 
hematological parameters were examined, as was the effect on percent lung consolidation. 
Neutrophil ftmction assays included: random migration under agarose, cytochrome C 
reduction, iodination. Staphylococcus aureus ingestion, chemotaxis, and antibody-dependent 
and antibody-independent cell-mediated cytotoxicity assay. Apoptosis was determined using 
a cell death detection kit. Euthanasia was performed at 72 hours after treatment. Statistical 
comparisons were made among the 3 groups of challenged-treated animals: saline-, 
danofloxacin-, and tihnicosin-treated animals. Comparisons were also made between non-
challenged non-treated animals (NCH) and challenged saline-treated animals. There were no 
significant differences for any of the neutrophil function assays or neutrophil apoptosis 
among the challenged-treated groups. This suggests that danofloxacin and tilmicosin have no 
clinically significant effects on neutrophil function or apoptosis. There were also no 
significant differences in percent lung consolidation among the challenged-treated groups. 
Significant differences were found between the NCH calves and the challenged non-treated 
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calves in several neutrophil assays, which were attributed to an effect of the Pasteitrella 
infection. 
Introduction 
The effect of antimicrobials on immune function is a burgeoning area of 
investigation in veterinary medicine, particularly in the context of diseases such as 
Pasteurella pneumonia in which the inflammatory process appears to have a major effect on 
clinical outcome. The authors have previously reported on the effects of two antimicrobials, 
danofloxacin and tilmicosin, on circulating neutrophil function in healthy beef calves. No 
significant differences were found between the two antimicrobials using assays that 
evaluated the ability of neutrophils to be recruited and attracted to the site of infection 
(measured via random migration under agarose and chemotaxis), the ability to phagocytose 
(measured via Staphylococcus ingestion), and the ability to kill bacteria as indicated by 
superoxide anion production (measured via reduction of Cytochrome C) and the 
myeloperoxidase- hydrogen peroxide-halide system (measured via an iodination assay) (Fajt 
et al, submitted). This is in contrast to several in vitro studies that found significant effects of 
various antimicrobials on bovine neutrophil function, although the concentrations of 
antimicrobial applied to the neutrophils were supra-therapeutic and therefore difficult to 
extrapolate to the clinical setting (Hoeben et al., 1997a;Hoeben et al., 1997b;Hoeben et al., 
1998;Nickerson et al., l985;Paape & Miller, 1990;Paape et al., 1991,Ziv et al., 1983). 
There has been a report of the in vivo effects of tihnicosin on neutrophils isolated 
from the lungs of calves with induced pneumonia (Chin et al., 1998). In that study, young 
beef calves were pre-treated with tihnicosin 18 hours and 15 minutes prior to the induction of 
Pasteurella pneumonia. The authors reported that tihnicosin increased the incidence of 
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neutrophil apoptosis at 3 hours after infection, but saw no other effects on neutrophil 
morphology or function. The significance of apoptosis of neutrophils in bovine respiratory 
disease has not been well established. Much of the damage that occurs to lungs in 
Pasteurella pneumonia in cattle can be attributed to the presence of neutrophils and their 
associated oxygen radicals and enzymes (Slocombe et al., l985;Breider et al., 1988;Breider 
et al., 1986). Therefore, a drug that causes the death of neutrophils through apoptosis might 
diminish the inflammatory response and damage to lung parenchyma. On the other hand, 
dead neutrophils cannoi perform their microbicidal functions, which might lead to the 
overwhelming of immune defenses by the infection. 
The challenge in P. haemolytica pneumonia is the potential for the bacteria 
themselves to affect neutrophil function, and the consequent difficulty in separating these 
effects fi-om those of the drug. In vivo studies have shown a decrease in circulating 
neutrophil chemotaxis associated with P. haemolytica infection (Henricks et al., 1987), and 
an increased chemiluminescence response which is an indication of oxygen-dependent 
bactericidal activity (Davies et al., 1986). In vitro, leukotoxin from P. haemolytica has been 
shown: to increase the production of leukotriene 84 (Clinkenbeard et al., 1994;Henricks et 
al., 1992), to activate the respiratory burst (Ortiz-Carranza & Czuprynski, 1992), to decrease 
the chemiluminescence response (an indication of oxidative metabolism) (Henricks et al., 
1990), and to cause morphologic changes consistent with apoptosis (Stevens & Czuprynski, 
1996). 
The purpose of this study was to investigate the effects of danofloxacin and tilmicosin 
on the function of circulating neutrophils and the extent of neutrophil apoptosis in the 
presence of induced P. haemolytica pneumonia. Danofloxacin is approved for the treatment 
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of bovine respiratory disease in Europe and South America, while tilmicosin is approved in 
the United States and Canada for the same indication. Assessing the function of circulating 
neutrophils instead of neutrophils that infiltrate the lung has two advantages: the samples are 
easier to collect, and more importantly, the potential local effect of the Pasteurella itself on 
neutrophil function in situ in the lung is removed as a confounding factor, although systemic 
effects oi Pasteurella are not removed. Circulating neutrophils are the source for recruitment 
of neutrophils to the lung, and assay of their flmction should be indicative of the functional 
ability of migrating neutrophils just as they enter the lung. Previous experience in challenged 
animals indicates that the majority of neutrophils isolated directly from the lung via 
bronchoalveolar lavage are degenerate and non-viable, and their activity cannot be evaluated 
(Fajt et al., 1999b). The other objective of this study was to evaluate the ^vo antimicrobials' 
abilities to ameliorate the extent of lung consolidation caused by P. haemolytica. 
Materials and Methods 
The experimental protocol was approved by the Iowa State University Committee on 
Animal Care. 
Animals 
Angus-cross heifers, approximately 6 months of age weighing an average of 181.3 kg 
(SD=19.0) on arrival, were purchased as a group from a single herd in Nebraska and shipped 
to allow 14 days of acclimation prior to the start of the study. Calves were pre-conditioned 
prior to their arrival at the study site with modified live viral respiratory vaccines; no 
Pasteurella vaccine was administered. There was no history of treatment with 
fluoroquinolone or macrolide antimicrobials prior to the start of the study. Animals that 
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exhibited any clinical signs of disease before P. haemolytica inoculation were removed from 
eligibility for the study and treated as appropriate. 
Animals were boused outdoors in concrete-floored pens with open front sheds as 
shelter (approximately 11.5 m%ead). They were fed free choice hay and a grain 
supplement balanced to allow weight gain of approximately 1.5 Ibs/head/day. The grain 
supplement contained monensin sodium at a rate of approximately 150 mg/head/day. Water 
was provided ad libitum. 
Bacterial Challenge 
Bacterial challenge was performed as previously described (Fajt et al., 1999c). A 3-
hour log phase culture of a frozen (-70°C) stock culture of Pasteurella haemolytica Type AI 
strain LlOl isolated from a calf with pneumonia was used. The broth culture was adjusted 
jj  ^  ^
spectrophotometrically to an approximate concentration of 1 x 10 colony forming units/ml. 
Concentrations of bacteria were verified after the inoculation procedure with standard plate 
counts. 
Culture fluid (20 cc) was administered to each calf through an equine bronchoalveolar 
lavage catheter.' The catheter was passed through the nares into the trachea as far as possible 
into a caudal lung lobe, then withdrawn approximately 20 cm so that inoculation would occur 
close to the level of the tracheal bifiircation. Culture fluid was placed in the catheter, 
followed by approximately 180 ml of air pushed in rapidly with a 60 cc syringe. 
Selection Criteria 
Animals were randomly selected for bacterial challenge from an initial group of 48. 
Two groups of calves were challenged with P. haemolytica: 18 animals during Week 1, and 
15 animals during Week 2. Of these animals, 12 were selected each week for treatment. 
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resulting in a total of 24 challenged-treated animals. At 20 hours after bacterial challenge, 
animals were clinically scored, and rectal temperatures were measured. The clinical scoring 
system used has been previously described (Perino & Apley, 1998). Briefly, a score of 0 is a 
normal animal, I is noticeable depression without apparent signs of weakness, 2 is marked 
depression with moderate signs of weakness without significantly altered gait, 3 is severe 
depression with signs of weakness such as significantly altered gait, and 4 is moribund and 
unable to rise. 
The successful induction of respiratory disease was defined as a rectal temperature of 
> 40°C and a clinical score of 1 or greater. The protocol dictated that animals that displayed 
a clinical score of 4 (moribund, unable to rise) were immediately evaluated for euthanasia 
and were not eligible for the study, but no animals exhibited this score. 
Using a randomized complete block design, a random number from a uniform 
distribution on the interval (0,1) was assigned to each animal meeting the selection criteria 
after bacterial challenge. Animals meeting entrance criteria were sorted by this random 
number, and the first 12 were chosen to be used for each week in the study. (Animals not 
selected were treated appropriately with an antimicrobial.) The selected animals were sorted 
by temperature and grouped into blocks of 3 from lowest to highest temperature. A random 
number from a uniform distribution on the interval (0,1) was again assigned to each animal, 
and the animals were sorted within the 4 temperature blocks by the random number. The 
first animal within each block was assigned to saline, the second to danofloxacin, and the 
third to tilmicosin. The above process was repeated for the second challenge group of IS 
animals, resulting in a total of 24 challenged and treated animals. 
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Four animals were also selected each week at random to be non-challenged, non-
treated controls (NCH), for a total of 8 NCH calves. 
Clinical Scoring 
Clinical scoring was performed by an investigator who was not aware of the 
treatment groups at 0,24,48 and 72 hours after treatment. Treatment was at 20 hours post-
challenge. The scoring system is described above under selection criteria. 
Antimicrobials 
Animals received one of the following treatments at 20 hours after bacterial 
challenge: danofloxacin mesylate"" (180 mg/ml) at a dosage of 6 mg/kg subcutaneously in 
the left lateral neck, tihnicosin" (300 mg/ml) at a dosage of 10 mg/kg subcutaneously in the 
left lateral neck, and saline (0.9%) in a volume equal to a dose of danofloxacin 
subcutaneously in the left lateral neck. 
Blood Sampling 
Blood samples were collected at 3,24 and 48 hours after treatment for hematology 
and neutrophil isolation. 
Hematology 
Blood samples were collected via jugular venipuncture and placed in tubes containing 
EDTA*. An automated cell counter*' was used to measure total and differential leukocyte 
count, erythrocyte count, hematocrit, hemoglobin, mean corpuscular volume (MCV), mean 
corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), red 
"" Advocin, Pfizer Inc, New York, New York. 
" Micotil, Elanco Animal Health, Indianapolis, Indiana. 
* Vacutainer, Becton Dickinson and Co., Franklin Lakes, New Jersey. 
" Cell-Dyne 3S00, Abbott Labs, Abbott Park, Illinois. 
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cell distribution width (RDW), platelet count, and mean platelet volume. 
Neutrophil Isolation 
Blood samples were collected via jugular venipuncture, and neutrophils were isolated 
as previously described (Fajt et al., 1999a). Samples were suspended with Hanks balanced 
salt solution to a concentration of 5 x lO' cells/ml for use in the neutrophil assays. 
Neutrophil Assays 
These assays have been previously described (Fajt et al., 1999a;Lukacs et al., 
1985;Roth & Kaeberle, l981;Roth & Kaeberle, 1981). The assays performed included 
random migration under agarose, cytochrome C reduction, iodination. Staphylococcus aureus 
ingestion, chemotaxis, and antibody-dependent and antibody-independent cell-mediated 
cytotoxicity assay using radiolabeled (^'Cr) chicken erythrocytes. 
Apoptosis was determined using a commercially-available cell death detection kit.'" 
Unstimulated levels of apoptosis were determined as was the percent apoptosis after addition 
ofcamptothecin(O.I and I.O ^g/mI), anapoptosis-inducingagent. 
Lung Lesions 
Animals were euthanatized with an overdose of barbiturate. At necropsy, lungs were 
removed from calves, and the percentage of consolidation of each lobe was visually 
estimated using a formula previously described (Fajt et al., 1999c). Areas of consolidation 
were sampled for histopathology and bacterial culture. 
MIC Determinations 
Minimum inhibitory concentrations (MIC) of several antimicrobials were determined 
for P. haemolytica used for the bacterial challenge as well as for P. haemolytica isolated 
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from the lungs of calves collected at necropsy. An automated broth-dilution method was 
used to measure MICs."" Custom plates containing several dilutions of the following 
antimicrobials were used: danofloxacin, enrofloxacin, ceftiofur, cefquinome, 
amoxicillin/clavulanic acid, colistin, spiramycin, oxytetracycline, trimethoprim/sulfadiazine, 
gentamicin, tihnicosin, spectinomycin, and tylosin. 
Statistical Analysis 
The following variables were natural log transformed prior to analysis: neutrophil 
chemotactic index, mean corpuscular volume, lymphocyte absolute count, monocyte absolute 
count, red cell distribution width, mean platelet volume, and mononuclear white blood cell 
count. The transformation resulted in residuals that were more normally distributed and also 
stabilized the variance. The least squares means were then back-transformed after analysis. 
The repeatedly measured variables from the challenged animals (3 treatment groups) 
including the neutrophil assay variables, apoptosis assay, and hematology results, were 
analyzed using a general linear repeated-measures mixed model.*'^ If a significant difference 
was detected (p<0.05) due to day of study or treatment effect, pairwise comparisons among 
treatments were made. NCH calves were compared to the saline-treated calves using a t-test. 
Statistical significance was defined as p<O.OS. NCH calves could only be compared to 
saline-treated calves and were not included in the overall general linear model because 
animals in the challenged groups were blocked by rectal temperature before treatments were 
assigned, and the non-challenged non-treated animals were not included in those blocks. 
'"' Cell Death Detection ELISA, Roche Molecular Biochemicals, Indianapolis, Indiana. 
"" Sensititre, Trek Diagnostic Systems, Westlake, Ohio. 
SAS Open VMS version 6.12 for an alpha, 1998, SAS Institute Inc., Cary, North Carolina. 
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Calculations were performed for the neutrophil assays to determine the power to 
determine a statistical difference at the 0.05 level (Stroup, 1999). Power was calculated for 
each contrast performed within each neutrophil assay when no significant differences were 
found. In addition, the least significant difference required to detect a difference with 80% 
certainty at the 0.05 level was calculated for each contrast. 
Percent lung consolidation data was transformed using the arcsine square root 
transformation before analysis, and was then analyzed using a general linear mi.xed model. 
Pairwise comparisons were made among treatments if a significant (p<0.05) treatment effect 
was found. After analysis, the least-squares means were back-transformed for presentation. 
Descriptive statistics were performed on the MIC values from P. haemolytica 
isolated from the lungs. 
Results 
Standard plate counts of the P. haemolytica challenge strain revealed a 
concentration of 2.9 x 10® colony forming units/ml in the first group and 1.7 x 10® colony 
forming units/ml in the second group of animals. 
Of the 33 animals challenged with P. haemolytica, 28 exhibited the selection criteria, 
and all selected calves had clinical scores of 1 or 2. At 24 and 48 hours after treatment, all of 
the challenged-treated calves had clinical scores of 1 or 2. By 72 hours after treatment, just 
prior to euthanasia, 2 calves in the tilmicosin-treated group exhibited a clinical score of 0, 
with all others remaining at I or 2, although there were no significant differences among the 
treatment groups in core body temperature (see Chapter 5). 
103 
Neutrophil assays 
For all of the neutrophil function assays (random migration, cytochrome C, 
iodination. Staphylococcus ingestion, chemotaxis, and cytotoxicity), there was a significant 
day-of-collection effect. There were, however, no significant differences among the 
challenged-treated groups (saline-, danofloxacin-, or tilmicosin-treated) for any of the 
neutrophil function assays at 3,24 or 48 hours after treatment. (See Tables 1-7 for 
summaries of the neutrophil function data, as well as the power to detect differences for each 
of the assays and the least significant differences.) 
When the NCH calves were compared to the saline-treated calves, there were no 
statistically significant differences between the groups for the neutrophil chemotaxis assay, 
the iodination assay, the unstimulated or stimulated Cytochrome C reduction assay, or the 
antibody-dependent cell-mediated cytotoxicity assay. 
Significant differences were found at 48 hours after treatment for neutrophil random 
migration, which was significantly lower in the saline-treated calves than in the NCH calves 
(50.5 and 90.4 mm", respectively). No differences were found at the other time points. 
At 24 hours after treatment, neutrophils fi*om the saline-treated calves displayed 
significantly higher Staphylococcus ingestion percentage than neutrophils from NCH calves 
(29.6 and 20.3%, respectively). No differences were found at the other time points. 
At 3 hours after treatment, the percent antibody-independent cytotoxicity was 
significantly higher for the saline-treated calves than for the NCH calves (20.4 and 2.3%, 
respectively), but no differences were found at the other time points. 
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There were no significant differences among the challenged-treated groups or 
between the NCH and the saline-treated groups for the cell death detection ELISA, whether 
apoptosis was stimulated or not (see Table 8). 
Hematology 
There were no significant differences for total white blood cell count or absolute 
neutrophil, lymphocyte, monocyte, eosinophil or basophil counts among the challenged-
treated groups. Total white count was significantly higher for the saline-treated calves 
compared to the NCH calves at 24 and 48 hours after treatment, for absolute neutrophil count 
at 3, 24, and 48 hours after treatment, and for absolute monocyte count at 24 and 48 hours 
after treatment. 
There were no significant differences among the challenged-treated groups or 
between the NCH and the saline-treated groups for total erythrocyte count, hemoglobin, 
MCV, MCH, or RDW. The mean hematocrit for danofloxacin-treated calves was 
significantly lower than saline- or tilmicosin-treated calves at 24 hours after treatment, and 
than tilmicosin-treated calves at 48 hours after treatment. The difference between saline- and 
danofloxacin-treated calves also approached significance at 48 hours (p=0.0522), with 
danofloxacin-treated calves being lower. The MCHC for saline-treated calves was 
significantly lower than that of NCH calves at 24 hours after treatment, but no other 
differences were found among challenged-treated calves for this parameter. 
There were no significant differences among challenged-treated groups or between 
NCH and saline-treated groups for mean platelet volume. Total number of platelets did not 
differ significantly among challenged-treated groups, but was significantly lower at 3,24 and 
48 hours after treatment in the saline-treated group as compared to the NCH group. 
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Lung Consolidation and Bacteriology 
No significant differences for percentage lung consolidation were found among 
treatment groups or among blocks of animals (blocked by temperature at time of treatment). 
Total percentage of lung consolidation in individual animals ranged fi-om 2.02 to 29.6%, with 
means of 18.1, 14.7, and 13.0% for saline-, danofloxacin-, and tilmicosin-treated animals 
respectively. 
P. haemolytica was isolated from 7 of the 8 saline-treated, 8 of the 8 danofloxacin-
treated, and 5 of the 8 tilmicosin-treated calves. Growth from I tilmicosin-treated calf 
revealed no P. haemolytica, but low numbers of colonies of Staphylococcus epidermidis and 
P. multocida. The MICs for the challenge isolate are shown in Table 9. MICs for all of the 
lung isolates were the same as the challenge inoculum with 2 exceptions: The MIC for 
spectinomycin was 16 i^g/ml for 3 isolates, and the MIC for oxytetracycline was 64 |ig/ml for 
2 isolates, l.O ^g/ml for I isolate, and < 0.5 |ig/ml for 3 isolates. 
Histopathological examination of samples from all lungs revealed changes 
consistent with subacute pneumonic pasteurellosis such as foci of necrosis surrounded by 
necrotic neutrophils, fibrinous bronchopneumonia, suppurative bronchopneumonia, and 
atelectasis. 
Discussion 
The number of animals displaying the desirable clinical characteristics after 
challenge with P. haemolytica (28/33 or 85%) suggests that this induction model will 
continue to be useful in pharmaceutical and other trials. As might be expected in the clinical 
setting, some animals began to display clinical scores of 0 by 72 hours after treatment with 
an antimicrobial. 
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The lack of significant differences in the neutrophil function assays in the 
challenged-treated groups is consistent with the authors' previous findings in healthy beef 
calves, where no differences were noted among the same neutrophil function assays between 
saline-, danofloxacin-, or tilmicosin-treated calves (Fajt et al., 1999a). Since danofloxacin 
and tilmicosin administered to healthy animals did not affect neutrophil fimction, then we 
hypothesized that the addition of induced Pasteurella pneumonia to the scheme should not 
affect neutrophil fimction differentially between the two antimicrobials either. The finding 
of no differences among treatment groups in the apoptosis assays is not consistent with the 
results of Chin et al. (Chin et al., 1998), who found that neutrophils isolated fi-om the lungs of 
tilmicosin-treated P. haemolytica-chdllenged calves exhibited increased apoptosis at 3 hours 
after treatment compared to sham-treated animals (although there were no differences at 24 
hours after treatment). One major difference between that study and the current one was that 
the current study used neutrophils isolated firom the blood and the former study used 
neutrophils recovered from the lung. In addition, animals in the former study were treated 
prior to bacterial challenge and there was not an unchallenged group, making it difficult to 
determine the role of P. haemolytica infection on the induction of apoptosis. It is possible 
that pre-treatment with antibiotic reduced the growth and metabolism of P. haemolytica at 3 
hours after challenge, resulting in less P. haemolytica-indxxced apoptosis, rather than a direct 
effect of tilmicosin on neutrophil apoptosis. 
Because no significant differences were found among the challenged-treated groups 
for the neutrophil assays, we calculated the power to detect these differences. Using a 
reasonable number of animals (8/treatment group), the power ranged from 0.05-0.65 
depending on the assay. This is mostly a result of the variability associated with the 
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neutrophil function assays. Because power is often not reported in studies similar to this one, 
there is no basis for comparison. However, due to the expense of the animals and the 
neutrophil assays, adding more subjects to the experimental design would have been cost-
prohibitive. 
The only differences in the neutrophil function assays noted among the groups were 
between the saline-treated and the NCH calves, in which differences were found in the 
random migration assay, the S. aureus ingestion assay, and the antibody-independent 
cytotoxicity assay. Neutrophils from saline-treated calves migrated significantly less than 
NCH calf neutrophils at the 48-hour time period. Activated neutrophils might be expected to 
display more directed movement (chemotaxis) rather than random migration under the 
influence of an infection, although this only appeared to occur close to 72 hours after 
bacterial challenge. Neutrophils from the saline-treated calves displayed higher S. aureus 
ingestion percentage at the 24-hour time period than NCH calves. Neutrophils fi-om the 
saline-treated calves also exhibited a higher percent antibody-independent cytotoxicity at the 
3-hour time period than NCH calves. The fact that the only differences were between the 
challenged-saiine-treated calves and the NCH calves suggests that these differences are due 
to the P. haemolytica challenge in some manner, perhaps as a result of circulating factors 
associated with the infection since the neutrophils were collected from the peripheral 
circulation. Challenged calves had higher core body temperatures as measured via 
radiotelemetry (see Chapter S), suggesting pro-inflammatory cytokine release, which could 
effect changes in neutrophil function. Certainly, P. haemolytica and its products have been 
shown to affect bovine neutrophils in vitro as discussed above. 
108 
As expected, there were no significant differences among the challenged-treated 
groups for the majority of the hematology parameters, but there were significant differences 
between the saline-treated and the NCH calves. The NCH calves were not challenged with 
P. haemolytica and would therefore not be expected to experience the increased leukocyte 
and neutrophil count typically associated with this infection (Vestweber et al., 1990). One 
exception to the lack of significant differences in hematology was the lower hematocrit 
associated with the danofloxacin-treated group, although the hematocrit remained within 
normal limits of the laboratory (24-46%). This phenomenon was also found in the authors' 
previous report on danofloxacin in healthy calves (Fajt et al., 1999a), although it has not been 
reported elsewhere for danofloxacin. It has been reported for temafloxacin, a human 
fluoroquinolone, which was removed fi'om the market due to reports of hemolysis with or 
without organ failure associated with an autoimmunity to erythrocytes (Blum et al., 1994). 
The other exception to the lack of significant differences among groups in 
hematology was the finding of lower platelet counts in saline-treated animals than in the 
NCH calves. This may be the result of increased disappearance of platelets associated with 
the pathophysiology of P. haemolytica infection, which results in damage to endothelial 
cells, hemorrhage and therefore platelet activation and subsequent microthrombosis (Weekly 
et al., 1998). Other investigators found decreased platelet survival at 6 hours post-
inoculation with P. haemolytica (Rashid et al., 1997). 
The lack of significant differences among the challenged-treated groups in percent 
lung consolidation can be partially explained by the individual variability of consolidation. 
Using this same induction model, the authors found a range of 5.0 to 37.5% consolidation in 
non-treated animals (Fajt et al., 1999c). Additionally, the time of necropsy (72 hours after 
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treatment) may not have allowed sufficient time for lesion healing that might have occurred 
as a result of antimicrobial therapy, or sufficient time for lesions to develop. In a previous 
experiment evaluating antimicrobial therapy, non-treated animals euthanatized on day 12 
after inoculation (day 11 after treatment) had significantly higher percent lung involvement 
(33±10%) as compared to treated animals (ranged fi^om 4-12%), with no significant 
differences between different antimicrobials (Ames et al, 1987). 
The changes in MICs fi-om challenge inoculum to lung isolate may be due to 
passage in the lungs; since no fingerprinting or strain analysis was performed on the isolates, 
this could not be confirmed. The MICs were similar enough across the majority of 
antimicrobials to conclude that the challenge strain was the same as the isolated strain. 
Differences of one dilution are considered non-significant, so the isolate exhibiting a MIC to 
spectinomycin of 16 |ig/ml should not be considered different from the challenge strain MIC 
of 32 jig/ml. 
Overall, these results suggest that there are no major, clinically significant effects of 
either danofloxacin or tilmicosin on circulating neutrophil ftmction and apoptosis in induced 
Pasteurella pneumonia. On the other hand, there is a significant effect of Pasteurella 
infection that results in changes in circulating neutrophil function in the absence of 
antimicrobial administration. 
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Table I. The distance neutrophils migrated under agarose in mm' (neutrophil random 
migration assay). Neutrophils were collected at 3, 24 and 48 hours after treatment with 
danofloxacin or tihnicosin (approximately 23,44 and 68 hours after challenge with P. 
haemolytica). NCH (non-challenged group) is arithmetic means; all other groups are least 
squares means. The lower portion of the table shows the least significant difference required 
between the groups to show a statistical difference, along with the statistical power to detect 
a difference. 
Time after 
treatment 
3 hours 24 hours 48 hours 
Saline 141.8 ± 15.1 47.5 ± 8.9 50.5 ± 8.7* 
Danofloxacin 127.8 ± 15.1 38.9 ± 8.9 37 ±8.7 
Tlhnicosin 106.5 ± 15.1 55.4 ±8.9 46.3 ± 8.7 
NCH 158.7 ± 10.41 70.1 ± 12.3 90.4 ± 17.9* 
Contrast LSD'(Power^) LSD^ (Power) LSD'(Power^) 
Saline vs. 
danofloxacin 
54.2 (0.11) 20.1 (0.23) 18.6 (0.54) 
Saline vs. 
tilmicosin 
54.2 (0.46) 20.1 (0.20) 18.6 (0.10) 
Danofloxacin 
vs. tilmicosin 
54.2 (0.20) 20.1 (0.65) 18.6 (0.30) 
•"Differences significant at p<0.05 
^The absolute value of the difference in the least squares means that would be required to 
declare a statistically significant difference at the 0.05 level with 80% certainty. 
+The likelihood of detecting a difference between the group means at p<0.05. 
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Table 2. The distance neutrophils migrated toward a chemotactic substance in mm" 
(neutrophil chemotactic assay) reported as geometric means with 95% confidence intervals, 
except for NCH which is arithmetic means with standard errors. Neutrophils were collected 
at 3,24 and 48 hours after treatment with danofloxacin or tihnicosin (approximately 23,44 
and 68 hours after challenge with P. haemolytica). The lower portion of the table shows the 
least significant difference required between the groups to show a statistical difference, along 
with the statistical power to detect a difference. 
Time after 
treatment 
3 hours 95% CI 24 liours 95% CI 48 hours 95% CI 
Saline 1.16 1.05-1.29 1.14 1.03-1.26 1.24 1.12-1.37 
Danofloxacin 1.18 1.06-1.30 1.19 1.07-1.31 1.24 1.12-1.38 
Tilmicosin l.ll 1.01-1.23 1.13 1.02-1.25 1.29 1.17-1.43 
NCH 1.12 ±0.04 1.12 ±0.04 1.17 ±0.06 
Contrast LSD' 
(Power^) 
LSD' 
(Power^) 
LSD' 
(Power*) 
Saline vs. 
danofloxacin 
0.196 (0.05) 0.196 (0.09) 0.196 (0.05) 
Saline vs. 
tilmicosin 
0.196 (O.IO) 0.196 (0.05) 0.196 (0.10) 
Danofloxacin 
vs. tilmicosin 
0.196(0.13) 0.196(0.11) 0.196(0.09) 
^The absolute value of the difference in the least squares means that would be required to 
declare a statistically significant difference at the 0.05 level with 80% certainty. 
JThe likelihood of detecting a difference between the group means at p<0.05. 
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Table 3. Percent radiolabeled S. aureus ingested by neutrophils {Staphylococcus ingestion 
assay). Neutrophils were collected at 3,24 and 48 hours after treatment with danofloxacin or 
tilmicosin (approximately 23,44 and 68 hours after challenge with P. haemolytica). NCH is 
arithmetic means; all other groups are least squares means with standard errors. The lower 
portion of the table shows the least significant difference required between the groups to 
show a statistical difference, along with the statistical power to detect a difference. 
Time after 
treatment 
3 hours 24 hours 48 hours 
Saline 34.4 ±2.3 29.6 ± 2.4* 18.0 ±4.2 
Danofloxacin 35.3 ±2.3 30.9 ± 2.4 14.0 ±4.2 
Tilmicosin 34.0 ± 2.3 30.1 ±2.4 18.4 ±4.2 
NCH 29.9 ± 2.6 20.3 ±4.6^ 7.1 ±2.0 
Contrast LSD^ (Power*) LSD^ (Power*) LSD^ (Power*) 
Saline vs. 
danofloxacin 
9.56 (0.06) 10.0 (0.07) 17.2 (0.10) 
Saline vs. tilmicosin 9.56 (0.05) 10.0 (0.05) 17.2 (0.05) 
Danofloxacin vs. 
tilmicosin 
9.56 (0.07) 10.0 (0.06) 17.2 (0.11) 
•Differences significant at p<0.05 
^The absolute value of the difference in the least squares means that would be required to 
declare a statistically significant difference at the 0.05 level with 80% certainty. 
$The likelihood of detecting a difference between the group means at p<0.05. 
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Table 4. Percent iodination as measured using opsonized zymosan (iodination assay); 
evaluates myeloperoxidase/hydrogen peroxide/halide system of neutrophils. Neutrophils 
were collected at 3, 24 and 48 hours after treatment with danofloxacin or tilmicosin 
(approximately 23,44 and 68 hours after challenge with P. haemolytica). NCH is arithmetic 
means; all other groups are least squares means with standard errors. The lower portion of the 
table shows the least significant difference required between the groups to show a statistical 
difference, along with the statistical power to detect a difference. 
Time after 
treatment 
3 hours 24 hours 48 hours 
Saline 15.1 ±3.2 16.2 ±2.4 15.5 ±3.2 
Danofloxacin 18 ±3.2 15.1 ±2.4 14.3 ± 3.2 
Tilmicosin 12.9 ±3.2 16.1 ±2.4 17.3 ±3.2 
NCH 21.3 ±2.9 17.6 ±2.2 20.0 ± 2.9 
Contrast LSD^ (Power) LSD^ (Power) LSD^ (Power^) 
Saline vs. 
danofloxacin 
11.7(0.11) 7.7 (0.07) 11.7(0.06) 
Saline vs. 
tilmicosin 
11.7 (0.09) 7.7 (0.05) 11.7 (0.07) 
Danofloxacin vs. 
tilmicosin 
11.7 (0.24) 7.7 (0.07) 11.7 (0.11) 
^The absolute value of the difference in the least squares means that would be required to 
declare a statistically significant difference at the 0.05 level with 80% certainty. 
JThe likelihood of detecting a difference between the group means at p<0.05. 
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Table 5. Optical density of neutrophils incubated with Cytochrome C and opsonized 
zymosan (Cytochrome C reduction assay). Neutrophils were collected at 3, 24 and 48 hours 
after treatment with danofloxacin or tilmicosin (approximately 23,44 and 68 hours after 
challenge with P. haemolytica). NCH is arithmetic means; all other groups are least squares 
means with standard errors. The lower portion of the table shows the least significant 
difference required between the groups to show a statistical difference, along with the 
statistical power to detect a difference. 
Time after 
treatment 
3 hours 24 hours 48 hours 
Saline 0.51 ±0.04 0.36 ± 0.04 0.41 ± 0.04 
Danofloxacin 0.49 ± 0.04 0.33 ± 0.04 0.40 ± 0.04 
Tilmicosin 0.46 ± 0.04 0.37 ± 0.04 0.45 ± 0.04 
NCH 0.44 ± 0.06 0.28 ± 0.06 0.35 ± 0.06 
Contrast LSD' (Power) LSD' (Power^) LSD' (Power^) 
Saline vs. 
danofloxacin 
0.16(0.07) 0.16(0.07) 0.16(0.06) 
Saline vs. 
tilmicosin 
0.16(0.15) 0.16(0.06) 0.16(0.10) 
Danofloxacin 
vs. tilmicosin 
0.16(0.08) 0.16(0.11) 0.16(0.14) 
^The absolute value of the difference in the least squares means that would be required to 
declare a statistically significant difference at the 0.05 level with 80% certainty. 
JThe likelihood of detecting a difference between the group means at p<0.05. 
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Table 6. Percent lysis of radiolabeled chicken erythrocytes (cRBC) in the presence of anti-
cRBC antibody. Neutrophils were collected at 3,24 and 48 hours after treatment with 
danofloxacin or tilmicosin (approximately 23,44 and 68 hours after challenge with P. 
haemolytica). NCH is arithmetic means; all other groups are least squares means with 
standard errors. The lower portion of the table shows the least significant difference required 
between the groups to show a statistical difference, along with the statistical power to detect 
a difference. 
Time after 
treatment 
3 hours 24 hours 48 hours 
Saline 40.8 ± 3.8 30.9 ±3.8 38.7 ±3.8 
Danofloxacin 41.6 ±3.8 32.4 ±3.8 34.1 ±3.8 
Tilmicosin 43.1 ±3.8 25.6 ± 3.8 35.0 ±3.8 
NCH 38.1 ±3.5 27.1 ±3.3 30.2 ± 6.0 
Contrast LSD^ (Power) LSD' (Power^) LSD' (Power^) 
Saline vs. 
danofloxacin 
15.8 (0.05) 15.8 (0.06) 15.8 (0.13) 
Saline vs. 
tihnicosin 
15.8 (0.07) 15.8(0.16) 15.8 (0.10) 
Danofloxacin 
vs. tihnicosin 
15.8 (0.06) 15.8 (0.23) 15.8 (0.05) 
^The absolute value of the difference in the least squares means that would be required to 
declare a statistically significant difference at the 0.05 level with 80% certainty. 
|The likelihood of detecting a difference between the group means at p£0.05. 
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Table 7. Percent lysis of radiolabeled chicken erythrocytes (cRBC) without anti-cRBC 
antibody. Neutrophils were collected at 3,24 and 48 hours after treatment with danofloxacin 
or tihnicosin (approximately 23,44 and 68 hours after challenge with P. haemolytica). NCH 
is arithmetic means; all other groups are least squares means with standard errors. The lower 
portion of the table shows the least significant difference required between the groups to 
show a statistical difference, along with the statistical power to detect a difference. 
Time after 
treatment 
3 hours 24 hours 48 hours 
Saline 20.5 ±6.1* 10.2 ±4.2 10.3 ± 3.9 
Danofloxacin 21.6±6.l 9.8 ±4.2 13.1 ±3.9 
Tilmicosin 22.8 ±6.1 11.0 ±4.2 10.8 ±3.9 
NCH 2.3 ± I.4» 1.4 ±0.7 0.7 ± 0.5 
Contrast LSD' (Power*) LSD' (Power*) LSD' (Power*) 
Saline vs. 
danofloxacin 
22.6 (0.05) 13.4 (0.05) 12.0 (O.IO) 
Saline vs. 
tilmicosin 
22.6 (0.06) 13.4 (0.05) 12.0 (0.05) 
Danofloxacin 
vs. tilmicosin 
22.6 (0.05) 13.4 (0.06) 12.0 (0.08) 
•Differences significant at p<0.05 
^The absolute value of the difference in the least squares means that would be required to 
declare a statistically significant difference at the 0.05 level with 80% certainty. 
{The likelihood of detecting a difference between the group means at p<0.05. 
Table 8. Cell death as detected using a commercially-available cell death detection kit. Unstimulated levels of apoptosis were 
determined, as was the percent apoptosis after addition of camptothecin (0.1 and 1.0 ^g/ml), an apoptosis-inducing agent. 
Neutrophils were collected at 3,24 and 48 hours after treatment with danofloxacin or tilmicosin (approximately 23,44 and 68 
hours after challenge with P. haemolytica). NCH is arithmetic means; all other groups are least squares means with standard 
errors. The lower portion of the table shows the least significant difference required between the groups to show a statistical 
diiTerence, along with the statistical power to detect a difference. 
Camptothecin 
concentration 
0 ug/ml 0.1 ug/ml 1.0 ug/ml 
Time after 
treatment 
3 hours 24 hours 48 hours 3 hours 24 hours 48 hours 3 hours 24 hours 48 hours 
Saline 0.32 ±0.06 0.36 ±0.06 0.34 ± 0.06 0.65 ±0.18 0.79 ±0.18 0.99 ±0.18 1.15 ±0.24 1.34 ±0.16 2.23 ± 0.40 
Danofloiacin 0.3 ± 0.06 0.4 ± 0.06 0.4 ± 0.06 1.03 ±0.18 1.2 ±0.18 1.09 ±0.18 1.24 ±0.24 1.49 ±0.16 1.68 ±0.40 
Tilmicosin 0.43 ± 0.06 0.47 ± 0.06 0.47 ± 0.06 0.82 ±0.18 0.92 ±0.18 1.0±0.18 1.04 ±0.24 1.37±0.16 1.98 ±0.40 
NCH 0.42 ± 0.07 0.54 ± 0.04 0.44 ± 0.05 0.96 ±0.18 0.82 ±0.13 0.81 ±0.11 1.39 ±0.30 I.13±0.I3 1.28 ±0.14 
LSD' (Powert) 
Saline vs. 
danofloxacin 
0.25 (0.05) 0.25 (0.08) 0.25 (0.11) 0.67 (0.37) 0.66(0.43) 0.66 (0.07) 0.95 (0.06) 0.62 (0.10) 1.61 (0.17) 
Saline vs. 
tilmicosin 
0.25 (0.25) 0.25 (0.25) 0.25 (0.30) 0.69(0.11) 0.66 (0.09) 0.66 (0.05) 0.95 (0.06) 0.62 (0.05) 1.61 (0.07) 
Danofloxacin vs. 
tilmicosin 
0.25 (0.31) 0.25 (0.13) 0.25 (0.11) 0.69(0.14) 0.66(0.23) 0.66 (0.07) 0.95 (0.09) 0.62 (0.08) 1.61 (0.08) 
^The absolute value of the difference in the least squares means that would be required to declare a statistically significant difference at the 0.05 level with 
80% certainty. 
^The likelihood of detecting a difference between the group means at p<O.OS. 
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Table 9. Minimum inhibitory concentrations in micrograms/ml of the challenge inoculum of 
P. haemolytica to antimicrobials, as evaluated using the Sensititre® susceptibility testing 
system. 
Antimicrobial Minimum Inhibitory 
Concentration (ng/ml) 
Amoxicillin/clavulanic acid < 1.0/0.5 
Cefquinome <0.06 
Ceftiofur <0.06 
Colistin <0.25 
Danofloxacin 0.06 
Enrofloxacin 0.03 
Gentamicin <2.0 
Oxytetracycline > 64 
Spectinomycin 32 
Spiramycin 128 
Tihnicosin 4 
T rimethoprim/S ulfadiazine 0.5/9.5 
Tylosin 64 
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CHAPTER 5. THE EFFECT OF DANOFLOXACIN AND TILMICOSIN ON CORE BODY 
TEMPERATURES IN BEEF CALVES WITH INDUCED PASTEUREUA PNEUMONIA 
A paper prepared for submission to the American Journal of Veterinary Research 
Virginia R. Fajt, Michael D. Apley, Kim A. Brogden, 
Terry L. Skogerboe, Valerie K. Karle, Arthur D. Dayton 
Abstract 
Objective 
To examine the effect of treatment of induced P. haemolytica pneumonia in beef calves with 
danofloxacin and tilmicosin on continuously recorded body temperature. 
Animals 
32 weaned Angus-cross beef heifers (160-220 kg) from a single ranch with no recent history 
of respiratory disease or antimicrobial therapy. 
Procedure 
Pneumonia was induced intrabronchially using log-phase cultures of Pasteurella 
haemolytica. At 20 hours post-challenge, animals were treated with saline, danofloxacin or 
tilmicosin. Radiotransmitters were implanted intravaginally, and core body temperatures 
were monitored from 66 hours prior to challenge until necropsy at 72 hours after treatment. 
For each animal, a baseline temperature was established based on pre-challenge body 
temperature. The area under the curve of the temperature-time plot was calculated for 3-hour 
intervals, and compared across treatment groups. Mean 3-hour interval temperatures were 
also calculated. 
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Results 
Areas under the curve for 3-hour intervals were not significantly different for any of the time 
intervals when challenged-treated animals were compared. Analysis of the mean 3-hour 
interval temperatiures showed significantly higher temperatures for saline-treated as 
compared to antimicrobial-treated animals for the majority of the time intervals, but no 
differences were found between the danofloxacin- or tilmicosin-treated animals. The 
circadian rhythm of temperatures pre-challenge returned at approximately 48 hours after 
challenge. 
Conclusions 
Danofloxacin and tilmicosin did not differ in their effect on mean 3-hour interval core body 
temperatures, but significantly decreased temperatures as compared to controls. 
Clinical Relevance 
Normal daily variation in core body temperature must be considered in the face of respiratory 
disease when clinical evaluation of feedlot animals is required. 
Introduction 
Body temperature as measured by rectal thermometer is a commonly used 
parameter for evaluating the health status of cattle. Finding an elevated temperature in the 
presence of other signs of disease is often categorized by the clinician as "fever." A true 
fever has been defined as "a pyrogen-mediated rise in body temperature above the normal 
range,'" implying a complex physiologic response to, for example, invading bacterial 
organisms in the case of bovine respiratory disease caused by Pasteurella haemolytica. 
Typically, fever has been measured at a single or a few time points in cattle under 
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experimental conditions, because taking an animal's temperature can be physically difficult 
and time-consuming. 
Continuous monitoring techniques utilizing radiotelemetry in cattle have been 
available for over 30 years and have allowed the gathering of temperature data in the absence 
of restraint. Most reports have involved the surveillance of normal body temperatures such 
as change in temperature during ovulation or under tropical or summer conditions. 
Radiotransmitters have been implanted under the skin, in the peritoneum, within the udder, 
and vaginally in order to monitor body temperature.'"^ The use of radiotelemetry to monitor 
temperature in diseased cattle has been reported in induced mastitis models in dairy cows 
and in respiratory viral challenge studies.^'^ Use of continuous temperature monitoring in 
disease models has the potential to allow comparison of pharmacotherapeutics or 
immunologic interventions (Fajt et al., submitted). 
The objective of this study was to examine the effect of danofloxacin or tilmicosin 
treatment of induced P. haemolytica pneumonia in beef calves on continuously recorded 
body temperature. 
Materials and Methods 
The experimental protocol was approved by the Iowa State University Committee on 
Animal Care. 
Animals 
Animals were approximately 6 month old Angus-cross heifers weighing an average 
of 181.3 kg (SD=I9.0) on arrival, purchased as a group from a single herd in Nebraska. 
Calves were pre-conditioned prior to their arrival at the study site with modified live viral 
respiratory vaccines; no Pasteurella vaccine was administered. There was no history of 
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treatment with fluoroquinolone or macrolide antimicrobials prior to the start of the study. 
Animals that exhibited any clinical signs of disease before P. haemolytica inoculation were 
removed from eligibility for the study and treated as appropriate. 
Bacterial Challenge 
Bacterial challenge was performed using the method of Fajt et al. (submitted). 
Briefly, a 3-hour log phase culture of a frozen (-70°C) stock culture of Pasteurella 
haemolytica AI strain LlOl isolated from a calf with pneumonia was used. The broth culture 
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was adjusted spectrophotometrically to an approximate concentration of I x 10 colony 
forming units/ml. Concentrations of bacteria were verified after the inoculation procedure 
with standard plate counts. Culture fluid (20 cc) was administered intrabronchially to each 
calf through an equine bronchoalveolar lavage catheter® as previously described (Fajt et al., 
submitted). 
Selection Criteria 
Animals were selected at random for bacterial challenge as previously described (Fajt 
et al., submitted). Two groups of calves were challenged with P. haemolytica: 18 animals 
during Week I, and 15 animals during Week 2, from which 12 animals were selected each 
week. 
At 20 hours after bacterial challenge, animals were clinically scored, and rectal 
temperatures were measured. The clinical scoring system used has been published.^ Briefly, 
a score of 0 is a normal animal, 1 is noticeable depression without apparent signs of 
weakness, 2 is marked depression with moderate signs of weakness without significantly 
altered gait, 3 is severe depression with signs of weakness such as significantly altered gait, 
and 4 is moribund and unable to rise. 
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The successful induction of respiratory disease was defined as a rectal temperature of 
> 40°C and a clinical score of 1 or greater, meaning noticeable to severe depression with or 
without signs of weakness. The protocol stated that animals that displayed a clinical score of 
4 (moribund, unable to rise) would be immediately evaluated for euthanasia and were not 
eligible for the study, although no animals in this study exhibited a score of 4. The study was 
a randomized complete block design, and animals were assigned to treatment as previously 
described (Fajt, et al., submitted). 
Four animals were also selected at random to be non-challenged, non-treated controls, 
for a total of 8 NCH calves. 
Antimicrobials 
Animals received one of the following treatments at 20 hours after bacterial 
challenge: danofloxacin mesylate" (180 mg/ml) at a dosage of 6 mg/kg subcutaneously in the 
left lateral neck, tilmicosin"' (300 mg/ml) at a dosage of 10 mg/kg subcutaneously in the left 
lateral neck, and saline (0.9%) in a volume equal to a dose of danofloxacin subcutaneously in 
the left lateral neck. 
Radiotelemetry 
Temperatwes were monitored using VHP transmitters"" encased in paraffin using a 
system described in Fajt et al. (model development study, submitted). The transmitters were 
implanted at least 3 days prior to inoculation of P. haemolytica as follows: A low caudal 
epidural was performed using 3 cc of lidocaine,"™' and then the transmitter was lubricated 
** Advocin, Pfizer Inc, New York, New York. 
Micoti], Elanco Animal Health, Indianapolis, Indiana. 
Minimitter® Company, Sunhver, Oregon 
Lidocaine 2% Injectable, Abbott Laboratories, North Chicago, Illinois 
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with sterile jelly" and placed intravaginally cranial to the vestibular muscle to ensure 
retention. The software was programmed to read body temperatiure every 5 minutes. 
Statistical Analysis 
The radiotransmitters were re-calibrated after study completion by the supplier, and 
correction factors were calculated for each transmitter to account for drift in temperature over 
the battery life of the transmitters. Because the transmitters are subject to electromagnetic 
interference, a procedure was established to remove outliers that did not fit with the 
surrounding data and that were therefore considered anomalous. First, observations of < 
37.5°C or > 42.5°C were considered outside of the normal physiological range and were 
removed from the data set. Then, an overall mean and standard deviation of the temperatures 
over the entire period were calculated. If an observation was greater than 3 standard 
deviations from the overall mean, the value was removed from the data set. Analysis was 
then performed on the subset of calibrated data with outliers removed. 
Two methods of analysis were used to compare core body temperatures among the 
treatment groups: area under the curve for 3-hour intervals and mean 3-hour interval 
temperatiu-es. For area under the curve calculations, an average core body temperature (in 
°C) over at least 48 hours was calculated for each animal from the pre-challenge 
temperatures. This average minus 1®C was used as a baseline for that animal. The area 
under the curve (AUC) above the baseline for each animal was calculated for each 3-hour 
interval pre- and post-challenge, and geometric means of the areas under the curve were 
calculated. For the mean 3-hour interval temperatures, the arithmetic mean temperature was 
also calculated for each animal within each 3-hour interval. Analysis of the 3-hour AUC and 
K-Y® Lubricating Jelly, Johnson&Johnson Medical Inc., Arlington, Texas 
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the mean 3-hour interval temperatures for the 3 chailenged-treated groups were analyzed 
using a general linear repeated-measures mixed model. These variables were also compared 
with a t-test to test for significant differences between the saline-treated and the NCH calves. 
NCH calves could only be compared to saline-treated calves and were not included in the 
overall general linear model because animals in the challenged groups were blocked by rectal 
temperature before treatments were assigned, and the non-challenged non-treated animals 
were not included in those blocks. 
Results 
The temperature profile for a single calf over the entire study is e.xemplified in 
Figure 1. This profile is typical, with a large peak in temperature within an hour after 
challenge, followed by gradually decreasing temperatures post-challenge and once treatment 
begins. An average of 96% (range 99.94-84.58%) of the data points collected for each 
animal were usable after the elimination of outliers. 
Rectal temperature data were available at the time that animals were selected for 
inclusion and were compared to transmitter temperature at the same time period. The 
average difference between transmitter and rectal temperature was 0.36®C, with a range of 
0.02-0.80°C. The transmitter temperature was lower than the rectal temperature for only 2 
calves. 
3-hour AUC Analysis 
The time periods of the trial were divided into pre-challenge, post-challenge (pre-
treatment) and post-treatment. Analysis of AUC at 3-hour intervals revealed no significant 
differences among the saline-, danofioxacin-, or tilmicosin-treated groups at any time interval 
pre- or post-challenge. The mean 3-hour interval AUCs for each treatment group are shown 
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in Figure 2. Comparing the AUCs for the saline-treated vs. NCH calves revealed 
significantly lower temperatures in the NCH calves from the first 3-hour interval after 
challenge until the 21-24 hour interval post-treatment, and at the 27-30 hour inter\ al post-
treatment. After 30 hours post-treatment, 3-hour interval AUCs of saline-treated and NCH 
groups were not significantly different. 
Mean 3-hour Interval Analysis 
Analysis of the mean 3-hour interval temperatures revealed significant differences at 
many time intervals between the saline-treated and either of the antimicrobial-treated groups 
(Figures 3 and 4). The pre-challenge temperatures at the 66-63, 63-60, and 57-54 hour 
intervals were significantly lower for the tilmicosin-treated group compared to the saline-
treated group: 39.2,39.1, and 39.1°C, and 39.7, 39.5, and 39.4°C for the three intervals for 
tilmicosin- and saline-treated groups respectively. No other differences were noted among 
treatment groups pre-challenge. 
Post-challenge but before treatment, danofloxacin-treated calves had lower mean 3-
hour interval temperatures compared to saline-treated calves at 9-12 hours post-challenge, 
and tilmicosin-treated calves had lower mean 3-hour interval temperatures compared to 
saline-treated calves from the 3-6 hour until the 18-21 hour intervals (Figure 4). 
Danofloxacin- and tilmicosin-treated groups differed at the 12-15,15-18, and 18-21 hour 
intervals post-challenge, with the tilmicosin-treated calves having significantly lower mean 
interval temperatures than the danofloxacin-treated calves. NCH calves had significantly 
lower temperatives than saline-treated calves from the 3-6 hour until the 18-21 hour interval 
post-challenge. 
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Danofloxacin-treated calves had lower mean 3-hour interval temperatures than saline-
treated calves from the 3-6 until the 30-33 hour interval post-treatment, from the 36-39 until 
the 48-51 hour interval, and for the 54-57 hour and the 69-72 hour intervals post-treatment 
(Figure 4). TiUnicosin-treated calves had lower mean 3-hour interval temperatures than 
saline-treated calves from the 3-6 until the 45-48 hour interval post-treatment, and for the 60-
63 hour until the 69-72 hour interval post-treatment. At no time interval post-treatment were 
there significant differences between the danofloxacin-treated and the tilmicosin-treated 
groups. 
The mean 3-hour interval temperatures for the saline-treated calves were significantly 
higher than NCH calves starting from the beginning interval until the 45-48 hour interval 
post-treatment. The mean interval temperatures of saline-treated calves were also higher 
from 63-72 hours post-treatment. 
Discussion 
The temperature time course of the untreated calves in this study followed an 
expected pattern: Pre-challenge, the calves experienced circadian rhythms as previously 
described with continuous radiotelemetry""'. In one study', body temperature was measured 
over the winter, and daily minimal temperatures occurred at approximately Sam and daily 
maximal temperatures at approximately 7pm. 
3-hour AUC Analysis 
One purpose of this study was to evaluate 2 methods of comparing body 
temperature data. 3-hour AUC calculations were used to attempt to remove individual 
variability in normal body temperature by calculating a baseline for each animal pre-
challenge. Comparisons of areas under the curve of 3-hour intervals revealed no differences 
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among the challenged-treated groups of calves for any of the time periods pre- or post-
treatment. It did reveal significant differences between the saline-treated and the NCH calves 
from challenge until 24 hours post-treatment. This is expected since there should be large 
differences in core body temperature between non-challenged and challenged animals, but it 
appears that AUC as calculated here may not be sensitive enough to evaluate smaller 
differences in core body temperatures. 
Mean 3-hour Interval Analysis 
In the current study, the lowest mean 3-hour interval temperatures occurred during 
the 6am-9am time interval in the 3 days prior to P. haemolytica challenge, and the highest 
temperatures occurred during the 3pm-6pm interval (Figure 3). An interesting exception to 
the time of lowest temperatures was in the NCH calves on the day of treatment: the mean 
interval temperature at the 6am-9am time interval was similar to the immediately preceding 
and succeeding intervals. This is likely due to the fact that all animals were moved from the 
pens to the working facility 100 yards away at approximately Sam to be treated, with the 
temperature increase in the NCH calves associated with increased activity. The circadian 
rhythm appeared to return to the challenged animals at 48 hours after challenge, when 
minimal temperatures occurred at the 9am-12pm interval and maximal temperatures at the 
3pm-6pm or 6pm-9pm intervals. To the authors' knowledge, this is the first description of 
interval body temperatures in cattle for any significant period of time after bacterial infection, 
so it is not known when the return to circadian rhythm is expected. 
It is not clear why the tilmicosin-treated group had some significantly lower mean 
3-hour interval temperatures than the danofloxacin-treated and saline-treated groups post-
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challenge but before treatment. Animals were handled in the same manner and received the 
same challenge dose of P. haemolytica, so an explanation is not apparent. 
Significant differences in mean 3-hour interval temperatures are shown in Figure 4. 
Daily rectal temperatures were significantly different in treated as compared to non-treated 
animals in one study of induced P. haemolytica pneumonia,'" but were not significantly 
different in another." One possible explanation for a lack of differences between treated and 
untreated animals is a difference in disease severity at the onset of treatment; for example, an 
increase in bacterial challenge dose has been correlated with an increased duration of 
elevated rectal temperatures.'' However, in this study, treated animals did have significantly 
lower mean 3-hour interval temperatures at the majority of the time intervals. 
It is possible that the group averages of mean interval temperatures eliminated any 
individual animal's normal temperature differences and that it was therefore unnecessary to 
perform the AUC calculations to attempt to eliminate that variation. However, as noted 
above, the tilmicosin-treated group had lower temperatures than the other groups at several 
intervals pre-challenge as well as post-challenge but pre-treatment. This implies individual 
variability in daily temperatures that was not eliminated by using means for the group. 
Another method of evaluating temperature and other cyclical clinical data that could be 
applied to these data is time series analysis. This method of analysis has been proposed for 
use in critical care monitoring in human hospitals as a way of identifying outlying data that 
require intervention'^ and was utilized in the previously mentioned study on body 
temperature in feedlot steers.' Our intent in this study, however, was to utilize a relatively 
simple method of analysis without relying on advanced mathematical techniques. 
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In conclusion, danofloxacin and tilmicosin did not differ in their effects on body 
temperature in this model of induced Pasteurella pneumonia. There were no significant 
differences among the challenged groups when 3-hour AUC was used as a variable, whereas 
differences were noted when mean 3-hour interval temperatures were compared. There were, 
however, significant differences found between the non-treated non-challenged (NCH) calves 
when compared to the saline-treated calves for both AUC and mean 3-hour interval 
temperatures. Further work with other disease models might illuminate whether AUC or 
mean interval temperatures are more appropriate variables to use in the comparison of 
treatments. 
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Figure 1 
Example of time-temperature profile over the entire trial as measured via intravaginal 
radiotransmitter after outliers were removed (see text for explanation). This animal was 
treated with danofloxacin. The vertical lines in the figure represent the time of challenge and 
the time of treatment. 
Figure 2 
Area under the time-temperature curve for 3-hour intervals for saline-, danofloxacin-, and 
tilmicosin-treated calves and NCH calves; P. haemolytica challenge was administered at 0 
hours. The hour on the graph corresponds to the beginning hour of the 3-hour interval over 
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which area under the curve was determined. Standard error bars were not included in the 
figure, but the range was 1.12-1.14. 
Figures 
3-hour interval mean temperatures for saline-, danofloxacin-, and tilmicosin-treated calves, 
and NCH calves; P. haemolytica challenge was administered at 0 hours. The hour on the 
graph corresponds to the beginning hour of the 3-hour interval over which temperatures were 
averaged. Standard error bars were not included in the figure, but the range was 0.138-0.146. 
Figure 4 
Statistically significant differences in 3-hour interval mean temperatures for saline-, 
danofloxacin-, and tilmicosin-treated calves, and NCH calves. Radiotransmitters were 
inserted at time interval -66, P. haemolytica challenge was administered at 0, and treatment 
was administered at 21 hours. The hour on the graph corresponds to the begirming hour of 
the 3-hour interval over which temperatures were averaged. See Figure 3 for actual 
temperature differences among groups. 
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CHAPTER 6. GENERAL CONCLUSIONS 
The overall goals of the research presented in this dissertation pertain to the 
investigation of the effects of antimicrobials on immune function in cattle. In this case, we 
examined the effects of danofloxacin and tibnicosin on neutrophil function and apoptosis in 
healthy and diseased cattle. In addition to examining neutrophil function, the effects of 
Pasteurella pneumonia and treatment with danofloxacin and tilmicosin on core body 
temperature as measured via radiotelemetry were examined. 
In the first study, the effects of danofloxacin and tilmicosin on circulating neutrophil 
function were examined in clinically normal animals. The results fi-om this study suggest 
that at therapeutic drug concentrations, danofloxacin and tilmicosin have relatively little 
effect on the functional abilities of circulating neutrophils in healthy animals. 
In the second study, we successfully developed a method of inducing Pasteurella 
pneumonia easily and consistently in weaned beef heifers by instilling live log-phase 
Pasteurella haemolytica cultures intrabronchially using a bronchoalveolar lavage catheter. 
Using this method, inoculation with P. haemolytica resulted in greater than 80% of calves 
developing clinical scores of >1, rectal temperatures of >40°C, and measurable lung 
consolidation from which Pasteurella haemolytica could be cultured. It was also determined 
that virtually continuous measurement of core body temperature via radiotelemetry was 
possible in heifer calves without surgical placement of transmitters. It was also determined 
that lung neutrophils collected via bronchoalveolar lavage were not sufficiently viable to 
allow evaluation of neutrophil function. 
In the third study, the effects of danofloxacin and tilmicosin on circulating 
neutrophil function were examined in animals with induced Pasteurella pneumom'a. The 
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results suggest that there are no major, clinically significant effects of either danofloxacin or 
tilmicosin on circulating neutrophil function and apoptosis in this model of induced 
Pasteurella pneumonia. However, it was determined based on comparisons between non-
challenged animals and challenged animals that received no antimicrobial that there is a 
significant effect of Pasteurella infection that results in changes in circulating neuu-ophil 
function. 
In the fourth study, the effects of danofloxacin and tilmicosin on core body 
temperature in induced Pasteurella pneumonia measured via radiotelemetry were examined. 
The two antimicrobials did not differ in their effects on body temperature in this model of 
pneumonia, although there were significant differences between the antimicrobial-treated 
animals and the saline-treated animals when comparing mean 3-hour interval temperatures. 
No differences were noted between antimicrobial-treated and saline-treated animals when 3-
hour AUC was used as a variable. As expected, significant differences were found between 
the non-treated non-challenged calves when compared to the saline-treated calves for both 
AUC and mean 3-hour interval temperatures, since non-challenged animals were not subject 
to the bacterial infection. 
The results firom these experiments suggest further research in the following areas: In 
the area of neutrophil function and interaction with pharmaceuticals, work is needed in the 
investigation of other antimicrobials and their effects on neutrophil function in healthy and 
diseased animals, the investigation of the effects of danofloxacin and tilmicosin on 
neutrophils in other disease models in cattle, validation of the no effects findings using larger 
numbers of animals since our power to detect differences was low in some assays, further 
investigation of the effects oi Pasteurella infection on neutrophil function and apoptosis in 
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the absence and presence of antimicrobials, and evaluation of the long-term effects on 
neutrophil function as pneumonia and clinical signs resolve (since our studies only examined 
neutrophils until 48 hours after treatment). In the area of body temperatixre measurement, 
further work with other disease models might illuminate whether AUC or mean inter\'al 
temperatures are more appropriate variables to use in the comparison of treatments. In 
addition, radiotelemetry in feedlot animals might be used to evaluate vaccine effects on body 
temperature and subsequent immune response, to follow animals further along in the course 
of pneumonia resolution to correlate temperature response to feed intake or lesions at 
slaughter, and to determine at what point animals begin to show clinical signs of pneumonia 
in relation to their core body temperature. 
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APPENDIX I. INSTRUCTIONS FROM CELL DEATH DETECTION KIT. 
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UM ONA ot the nudeoaomea la ttghtly compleied with 
the core Metonea H2A. H2B. H3 und H4 and ia (here-
fore protected from deevege by the endonudeaae 
^4). The ONA fTagmema yielded am ttacrete 
ffluttlpiesof en 180 bp auburut which la detected aa a 
'ONA ladder* on agaroae geia after eitractton and 
leperstion of the fregmenlsted ONA. The ennchmant 
of mono* end oHgonudeoaomea in the cytoptaim of 
the apoptotte cell ia due to the tod the! DNA 
dagradihon occun a«ml houn before plaima 
membrane breakdown C5). 
Apoptona is the most common fdrm of auMryoticcell 
deeth. It occurs eg. during embryogeneaia tn paraiel 
with the deletion d autoreect^ e T ceis during thymic 
metuiatton. In aeneseenee d neutrophil polymoiphi. 
and foUonMng removtl of ipeofle growth fSctora  ^Nhe 
11-2. or the eddWon of phystologicsi itimmuil Hfce 
tumor necroata factor end glucocorticoids (B.7). 
Apopioeia is slao inducsd by eywonc T lymphocytea 
and netursl Uier (NK} ceHa and by loniting 
rsdMon 00] end monoclonal antibodies like 
antl-Faa 0 H und aMMPO-t 0113). 
MMrtitw efttt CMI OMii OaMctfaa CUtAs 
- No radtofSDiopea are used. 
• QuenduMy iniuieiiient d eel dsrtt 
• No prelMng of the eons required: this stfows the duentiflcation of 
apegM elM in oMmMch do not pnilMi Mfea e.o* froihiy iMMidL «i#DiufMro«li Mtf orguiopiM^ 
• OsiMtion of MrtDn^swDCiHed PWA f^ igwienti In one lmmunoeaaey> 
lieimmung the imemudaoeomsl gegnidadon of gsnomie ONA 
ooeurino durtng spopiesia. 
• The smibodtosussd ere net nodes apsdHcOstsfminstion of 
apoptoHi fn CON tyiiefiit from vtrouiipidts. 
• Results obttmsdeorreiete to those obtsined by itandsrd methods. 
• HigfUyssnsitfve; less oelsnquirsd to obtiin results 
2. Product description 
2.1 KR contents 
Boole Cep label Comem 
1 white AntHhistone Monodortal antibody Irom mouse 
(done HU-4}; lyophiitfed: 
ftabtiued. 
2 red AnO'DNA-POD IMonodonat artlibody from mouse 
(done MCA«33X confugeted with 
perowdaae: lyophittnd; itabdiied. 
3 white Coeiing buffer 10 » conc: lotubon. 2 mL 
4 green WSahmg buffer to K conc: solution 40 mL 
s red Incubetion buffer Reedy to use solution, too ml 
6 whse Subatraie buffer Solutioa ready to dtasoNe 
theABTS*' tablet. 15 ml 
7 whtt A8TS 
aubatrateteblet 
1 piece, suffiaent for 
IS ml substrate solution 
B Microtiierpiete \2 mcratiter ptate moOiMs 
9 wena. eech); frame. 
AdhesMa cover toils to cover 
mootiterplete. 
Macsasia*! IMMMIMM 
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U Twi »«liiclpl« (Mii^ ilefc nj»A) 
(5*^ ° O^O 
o°T 0%"° 
anii'hisioiW' lampte •nti'ON*^  *BT5~ 
coaced MTP conumifig POO tubstritt 
nudmoiMs 
The atwy is twMd on tht quantiiaiivf sarnhMCh* 
eniyme'tminunoMsay^phnopte usng mouse 
monodonsi sniibodMS dkecied aotinst ONA and 
hifiooML reapeclivefy. This siloM the spcafie 
detefm i^on of mono> and oligonudeoiomes tn the 
cytoplasmic freown ol eeU hruies. 
In the Hfst incubitnn step. anthhiitofW antttx)dy is 
Axed adsorptivtty on the wall of tht microtiter pttte 
module. SubSMtuantly; non^spedfie tending stas on 
the wail are saturaied by treatment with incubation 
buffar (• blocfcing soiutionX Ouhng th« second 
mcubauon step, the nudeoaomes containad in th« 
sampit bind vie their histona compontnts to the 
immobirind wiO*ius(one antibody, (n (he third 
irtcubation step. anti*ONA'peraiidasa CPOO] reacts 
with the ONA'part of the nudaosome. After removal of 
unbound pttvidatt eon)uoatt by a wMhing step, the 
amoum of paroiidiM retaintd m tht invnunocompiti 
« determined photometncaRy with A6TS 
(2J'«azino-di>0>ethylb«uthiamine sulfonate 
u a substrate. 
2J SpecWcity 
Anti htsione anobody reacts with the htstones Ht. H2A. 
H2B. H3 and Ha of various spectes. e.o. man. mouse, 
rat. hamster, cow. opotsum. lenopus. AnU>ONA POD 
antibody binds to iinole« and doubie<>«randed ONA. 
Therefore, the EUSA allows the detection of mono* 
and oligwucieosoffles from venous tpaaes and may 
be appiM to maesure apoptotic ceil death in many 
ditfaram tea ayatema. 
2.a SlaMMy 
The Ut ia stable through the control date prated on the 
kit when stored it 2*<'C. 
3. Prepamkm of ih« Mluilofit 
The hit cont«ns all the reagents needed and in 
suf rwaent amounts for 96 tests. Redistilled water should 
niweys be uied for reconitttutton and ditutton 
purposes. 
3»l WecBwatHiitloii of lyopMHnCM 
*1111 Meieiii (teHli I) 
Reoonattiuiethelyophiliiiiein i miredistweterfor 
to mm end mil thoroughly  ^SlabWtyof the Mlution: 
stable (or 2 moftths. stared el 2*t*C 
Anll-OfM^O OMIlle a) 
Reconstiiutt the lyophHUate in i mi redist water for 
to mm and mis thoroughly. Stabtttyof the lokitton; 
stable (or 2 mornhi. stored et 2-t*C 
U Piepieliow of Hie woriiing aokilioiia 
L Coeting aehibpn 
Pradilute I mi coating buffer concentrate (bottle 3) 
with 9 ml radist water. Shortly before use. dilute 
I mi anb-histone entibody (bottte t. reeonttituted) 
tMth 9 ml coating buffer. Stabiiity of the soluuon 
cannot be stored, prepare unmediatety be tote use 
IL Waahlng aohibon 
Warm up at IS>25*C washing buffer concentrate 
(bottle «) and dilute *Q ml in 360 ml rectist water 
and mil ttwcougtxty Sttbtiily of the solution 
stable for 2 months, stored at 2-8*C 
lit Seiwple aokition 
Depends on tlw ceil system used snd the extent of 
celt death (see t»low sample prettaration). 
eiampie: dilute 25 ^1 sample in 225 til incubatton 
buffer (boRle 51 Stabiiity of the sample soluuon-
stable for 2 days, stored at 2-8*C 
IV. Contugela sdulloii 
Oiluta I ml anb*ONA>POO (bonie 2. reconstitutM) 
with 9 ml tncubatwn buffer (bottle 51 Stability of 
the conjugate solution cannot be stored, prepare 
immediately before use. 
V. Sutemie aoliitlofi 
Dissolve ABTS substrate tablet (bottle 7] m 
subsuate btiffer (total volume of bottle 6) The ABTS 
solution reacts to light on eiposure over a longer 
(wnod. Stability of the solution: stable lor I montfv 
stored at 2'0*(X protected from light. 
4. StmpfM 
4.1 Sampte materiel 
Cytoplasmic fmeltons Oysates) of cell lines, ceils ax mo 
(see sample preparation) or tissue homogenates (ts) 
a.2.Sanipl« pfepamkm 
Dilute the cells with culture medium to obtain a 
suitable cett concentration. Depending on the ceil type 
and the c«U>deain-induong>agent. the ceil number per 
test haa to be determined and optimiAd The loilowing 
cellular model system, m particular the cell number per 
test, ts an eiampie for a test procedure. As a model 
system (or cell death, camptotheon (CAM) was used 
as tt)e apoptosis*induang drug. The tests were 
performed with the humen myelogenous leuiiemic 
ceil line HL60 ^ TCC: CCL 240) as target cells (U*I7) 
4X1 Indudiofi of eci death (eeWult eeaey) 
Dilute etponentiatty growmg Hloo cells with culture 
medium to tMam a caU concentration of cells/ml 
and transfer into Eppandorf tubes (500 i^/tube • 
S »10* cells/tube). Thereafter add 500 id culture 
medium with different concentratmns of CAM 
(0CAM/mt to a (ig CAM/mtV Use value 0 lig^nii 
as a negatMe control for the ceiluiar assay (« viable, 
untreated cells). Close tubes loosely to allow further 
eschange of gas and incubate at 37*C m a 
COrMKubetor for 4 h. 
4.3 J SMRpta After incubetion. centnfuge the cells ion an Eppendorf pwceaeiBi centrifuge eti500 rpm(» 200 itg) for Smin. Discard 
the iupemetem and resuspcrid tfte ceN pellet m i ml 
oAuit medkim. After an other centnfugation step 
0500 rpm. 5 min) resuspend the cell peHet with 500 ^ 1 
mcubaUon buffer (bottle 5) per tube (i x to' celt/mi) 
mis thoroughly end ineubete the sample lor appror 
ao min et room tetnperature («lyus). Centnfuge the 
lysate at tSOOO rpm (• 20000 « g) for ID mm and 
remme 400 |d of the supernatant (» cytoplasmic 
fraction) carefuKji Do not shake the pM C* cell 
nuclei, contaenng high molecular weight unfraomen-
tated ONAX 
2 Rodte Molecular Biochemicab 
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8. NOIM 
•.1 BacktrouiitfoftfM 
Dtpcnding on the individual anay eonditio(«» tfia 
background vaiua Oncubatwn buffer inMaad of sampla 
uiuDon) Qi thm immunoaiaay may vary. Under normal 
conditions (he bachqround la bekMr 100 mU after IS mm 
U Meoaliv* control for c*i tfMth InAietioii (caflular aaaay) 
Depending on cell cuHura conditions, each 
asponantially growing permanent ceil culture contains 
a certain amount of deed ceils (normalty approx. 3-a%). In the immunoassay, these inherent deed cella 
in the untreated sample Mhout ca(M}eeth>indudng> 
sgerM) wH cauee e certain sbaorbanca value. 
Depending on tfte amount of dead oelis» this value 
may esceed tha ebsorbence value of the immunoassay bads^nd. 
1 M»llNA.KflltlC1iaD1«icAl»«/Cyua0.2S1 
2 DM«ltar4Wya«A.H nsanimniMri rariiyT.n& 3 Snofx. L A.« n (lf7«l ataenaw i lU. 97 
« sncfLiiw fiai(iantiAMwaB^Mas.2S7 S OulW;llCwidCo#wi.J.iOlint>iiW"i1*i.2ie 
• SnnlviM tl«.(1M)ABeMMt4cMSoUS«sa.lBt 7 J.«lintiO]>tatJMinatlSa.Sei. 
a *iMi.j KOMOAiar«Mtae.tsi 
a W)«a.AH(1M71MJIwCHM19aupplL7». 10 VMM r. vid Qnv«ma H. (issfl *ic / AiMc ftof aa. O ti Van«nai«.S attL 08*11 i£« MM iaa.tU7 
12 rfMfti.c.<«ri {taM)temiaa.30i 13 OtMi:A.«laL(1St2).lABCCta«fa7.107QS 
u 0iiaMia.a«taL0iai)£«CifA«ias.77 IS CMama&MaL(itst)C«C«fA«ies.«as IS OwynkMwcz. £ ft •! (>•§}) QMrnaffy IS. 7SS tr KubMt.M «•! (1SS3) limint Cong AMlvt.CV10I.CeiDrMioSonnQ». USA. It LMCM.flil(ieMU*«ni«ig< ISlinS 
''Airs a • irwMmani or • MmiMt ol IM RacM CfMio 
•J PosMm control for tlMSfUSA CHwaiAdwaa Coumry 
Tbo negatlvt eonuol of the ceNular assay will cauee a 
certain absortMnca value in the Immunoassay 
Oee 0.ZX Therefor*, a positlvo control for the 
immunoassay as an additional component is not 
necessary. How*^ «r. if an eitra pos  ^control for the 
immunoassay is destrsd. It cm bt prepved foHoMng 
this simple procedure; 
t^nfuge sn aliquot of imtreaied cells C5 x i o* cells/ 
tube in 500 ^  sea section 4.2.1.) at 1500 rpm for S mia 
Discard the supernatant, resuspend the caN pellet in 
500 |U hypertonic buffer (10 mM Tris. pH 74.400 mM 
NaO. 9 mM CaO) artd 10 mM MgO}) and incubate at 
37*C for at leest 2 K Thereafter, ipin down the cell 
fragments at 18 000 rpm. remove the supemstsnt 
ctreftilfy. diiuta the supernatant t :S with mcubation 
tMffar (feiolUo 5) und use this sample ss a posttve 
control for (he immurwassay. 
6.4 Detection IMl 
The eiact detection limit of dying/dead ceOs in s 
particular sample strongly dspe  ^on the kinetic of 
cell death, the cytotoiie agent used and the amount of 
sffected cells m the total caN popuiatloa Using 
HL60/CAM aa a cellular modal system for cen deeth. 
(he immunooaaay siows the spe  ^detection of 
mono* and oUgonudeosomes h the cytoplasmic 
fraction of 9 x 10* cans/ml (* SO call equivalantiAMll) 
(see fig. 2). 
gieBwianetaawiwe»CWiBiiiWM|artHKOMM»r4mi irc w Wi •§ nwaee* iwm oi He iwm we 
hup'y/blochawijoctie.com/pacfc-lnaett/l S44€7Ba.pdf 
AffMOM Wt IS« USSi AMMifla (R1 sm TMS: <ililll (01] TTt V. MalMi (03) W 
•SIO;lntf«SBnt)MSSn«;CBI«*(«SQ)asa 7060.(800) 3St2070:CMtoOOS6(7)» 
si7V(GMr«qooMO]nnosa(iMB);CMi*seii s4wassftCi>iniioo87»t.>4im7. 
eiMii iiipMi (Dn«) a S4. u tx-z Ooinie «4S 3S3 ise ss; lavpi m ms i7is. 
nwiu (Oi) at: ring o* is m lo ir. osiwini (oean 7m «m. omn a (od «7 
«oas;iiMtii«ia(SU)2MBme;Mtaooi)(n)«ST a ir.in«MMtot9(D3i)nais» 
«ii7U;iieNoeM2i3 0inM«oeN3ii7aMSt:iofeeiin3««0 3i ii.iwiom?*; 
•I»4tst: JapM 01 M33 SltS; 0QtS«<l*7« «S 77: MfM 02«}-3*7l «s00. KmmN 90N6-4a3 IS 00; UMnaiMia 0BSS3>«ai«ai; MMoiito SO ton 7U M3». MmIm (9) »7 
•osT-. iiodieiweB (BS) sse «ei n zeieK (OS) ITS •! 87: miwte ee23».i.w 00 04. Wol••laoyOB0fltHlli»plM»(SMl>IO7»—NlWd IIS0»»iSS>306.Full 111(01) 
•t717Tr.llipaaBiallMl«ldt00e«en«l;MMla(*S)l3t79SSS3SfM:(*t|S2t7MaSII. 
I •OSS i «eiam; ooss m om im* mhob (oi n oss ae (»i) >79 st: Istfh loMa SI ssa osai: Ipaai (m 301 Ml i: fwMM (OS) MA OOOOt iHtaM —t (41) 70S SlSt; Wmi (BI) 7S8 7131IMM «(2) Z7i 07 
osttnwfci>wNiOoso2H2isnsotiiiiaiiH i<iiii(oeoBiaa)S7s:uiA(soo)«a»»o 
n OMK t«Mi (0 CMI. • • scMn. 
Rom DiegnosUca (*fiibH 
Aocha Mdeculaf Biochemlcals 
SandhoferSlraaaa ttfl 
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Prtdiluit iht nsuftmo lupsntauni 1; 10 With 
ineubMion bufftr C«1 x 10* ctfl •qumlanu^ml) tnd 
dettct tttt midaotoaits in tht MNnplt by mmunoMMy 
(ff tMlow NCtton S.). 
KitrtcoRinMndidthMttwumpinirtilortd in 
•liquMtt -tSto '2S*C If tlMycannotbtitfltdon 
iht Mm* day or. at tht fatnt one day latar. 
n 
U WMMnt 
flf.!: ImMmmm in aia fyiiptoMi «l 
•WM «Ml canfMIMM. HLCO CMt ««rt ftpeMd ler • A M 
»7*C IB Jiw—m CAM uwciwi wow m iMwiftid tflo» Alur cH 
wd GtntnfuQMw iMcyMpMnMc tKiuiWMfvpiMikiiid 1:1C wi» maimBh bunm Mwl mil to moamimt D» ClttA (•I m tO*eaaiqu«Mian(t/M>i » lO'cMtqunMtmi/MN; 
io»aii>«i<iowo>otaiuwnwmnfowwn.s>ttt«rw>n»oww 
ttmr H iwn (Q • <nnlwww 
5. WoHiIng proctdun oC Um QJSA 
S.I CoaUngofttMMT^HiiatfiilttwMi 
U WiLaailni 
Removt solution thoroughly by tapping or suctioa 
Rinse tMils three times «Mth 2S0-300 Mashing 
solution 00 per well and remove washing solution 
earefuOy. 
M iHciititlwi wWt sample aolurton 
Pipette <00 |il of sample sohition (III) mto each well of 
the MTP>modules. For determination of the Oacii-
ground of the immunoasaay. ppette 100 til per well o( 
incubation buffer (botUe 5) mto two wells. C^^ er 
MTP-modules tightfy with the adhesive o r^er (oil 
included and incubate for 90 mm at IS>2SX. 
MWaaMnt 
As descnbed under 11 
U InciiiMlloii «Mi snlMINA-pafoaldMa 
Pipette 100 t»l of coniugate solution CIV) into each well 
of trie MTP-moduiea. eicept the blank position. Cover 
MTP-modules tightfy with the included adhesive covei 
foil and incubate for 90 mm at room temperature 
t.7 WnMng 
As descnbed under U 
M Su6airal«r«actlofi 
Qapsed tMie; approi. 5*6 h. 
Temperature: I5>29*C 
It IS recommended that the cytoplasmic (ractlona are 
diluted with incubation buffer to obtain a sample 
solution corresponding to approL lO^^ tO* cell 
eqmv i^B/mt. The amount of 10 • celt equwalenta/ml 
« defined as the volume of ce9 tyiate which 
corresponds to lOxceHa/mL 
For the immimoaasy. it is recommended that the 
samples be meeaured and titrated in duplicate. Titrate 
also the negative control of the caHutar assay (• viable 
ceiia}. Thia ailowt calculation of the eniiehment factor 
(seebeiowX 
Pipette 100 iii of substrate solution (V) mto each well 
of the MTP-modules and incubate on a plate shaker at 
2S0 rpm untri tfte color development ts sufficient for a 
photometric analysis (approi. after lO^TOmin). 
Homogenue the content of the weDs by careful lappmg 
at the MTP edgM and meiiure at tOS nm agaimt 
subMrate solution CV) as blank. 
9.10 Intefpretailofi 
Pipene lOO tU coating solution 0) into each wen of the 
MTP-modules: cover MTP-modults tightly with the 
adhethie cover foM indudad and Incubate for l h at 
room temperature CaRemetivefy owt night at 
Remove coating solution thoroughly by tapping or 
suction. Pipette 200 incubetion buffer (bottle S) into 
eech wei of the fMTP*modulet. (^ r MTP*modulet 
oghtty with the adhMlve C9«r foil mdudid and 
mcubete for 30 min at 19'25*C 
Average the vtluet from the double absortMnra 
measurementa of the samples. Subtract the 
beckgnjund value (see bek>w) of the immunoassay 
from each of these averages. Calculate the specific 
enrichment of mono> and oligonucleosomes released 
mto the cytoplasm fnjm these vakies using the 
followmg formular 
mU of the sample (dying/deod cells) 
mU of the corrMpoodmg control (viable cells) 
mil - absorbanca [10**) 
• enr^ hment factor 
Sample* with vaKiea eiceedtng the measurement 
range of the photometer shoukl be diluted and 
run agam; the corresponding control wmpie (viable 
cete) has to b« diluted by the same (actor Pieese note 
this dHutton factor when calculating the emchment 
factor. AMfnatHrely. the substrate reaction time can be 
decreaaad. 
3 Roche Molecular Biochemicals 
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APPENDIX 2. INDIVIDUAL CALF TEMPERATURE PROFILES FROM CHAPTER 5. 
In this experiment, healthy weaned heifer calves, approximately 6 months old, were 
challenged intrabronchially with approximately 1x10® colony forming units/ml of 
Pasteurella haemolytica. Approximately 20 hours after challenge, calves were treated with 
danofloxacin mesylate (180 mg/ml) at a dosage of 6 mg/kg subcutaneously in the left lateral 
neck, tilmicosin (300 mg/ml) at a dosage of 10 mg/kg subcutaneously in the left lateral neck, 
or saline (0.9%) in a volume equal to a dose of danofloxacin subcutaneously in the left lateral 
neck. Eight animals were also used as controls, and were neither challenged nor treated. 
Core body temperatures were recorded continuously over the entire experiment for each 
animal using an intravaginal radiotransmitter. The graphs in this appendix represent body 
temperatures for each aiumal in the experiment, with outlier data points removed according 
to the description in Chapter 5. The vertical lines in the graph represent the time of challenge 
and the time of treatment. 
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Figure 1. Animal No. 4; treated with danodoxacin 
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Figure 2. Animal No. 5; treated with danofloxacin 
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Figure 3. Animal No. 6; treated with saline 
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Figure 4. Animal No. 7; treated with saline 
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Figure S. Animal No. 8; treated with danofloxacin 
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Figure 6. Animal No. 14; treated with danofloxacin 
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Figure?. Animal No. IS; non-challenged 
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Figure 8. Animal No. 17; treated with saline 
42.5 
600 800 1000 1200 
Obsvrvation Number (approx. every 5 minutes) 
1400 1600 1600 
Figure 9. Animal No. 20; treated with danofloxacin 
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Figure 10. Animal No. 26; treated with saline 
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Figure 11. Animal No. 30; treated with saline 
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Figure 12. Animal No. 31; non-challenged 
39.8 
39.6 
U 39.4 
S 39.2 
39 
38.8 
38.6 
38.4 
38.2 
0 200 600 800 400 1000 1200 1400 1600 
Observation Number (approx. every 5 minutes) 
Figure 13. Animal No. 32; non-challenged 
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Figure 14. Animal No. 33; treated with saline 
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Figure IS. Animal No. 34; treated with tilmicosin 
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Figure 16. Animal No. 35; treated with tilmicosin 
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Figure 17. Animal No. 37; non-challenged 
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Figure 18. Animal No. 38; treated with danofloxacin 
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Figure 19. Animal No. 39; treated with tilmicosin 
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Figure 20. Animal No. 40; non-challenged 
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Figure 21. Animal No. 42; treated with tilmicosin 
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Figure 22. Animal No. 43; non-challenged 
42.5 
42 
41.5 
0 
1 
I 
e 
I 
I 
s 
u 
39.5 
38.5 
600 800 1000 1200 0 200 400 1400 1600 
Observation Number (approx. every 5 minutes) 
Figure 23. Animal No. 45; treated with tilmicosin 
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Figure 24. Animal No. 47; treated with saline 
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Figure 25. Animal No. 48; non-challenged 
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Figure 26. Animal No. 49; treated with saline 
39.8 
39.6 
U 39.4 
I 
^ 39.2 
C 
& 
38.8 
a 
J 38.6 
38.4 
38.2 
800 1000 1200 1800 0 200 400 600 1400 1600 
Observation Numlaer (approx. every 5 minutes) 
Figure 27. Animal No. 52; non-challenged 
42.5 
42 
41.5 
U 
i 
I 
e 
I 
I* 40 
a 
§ 
u 
39.5 
"W 
39 
38.5 
800 1000 0 200 400 600 1200 1400 1600 1800 
Observation Number (approx. every 5 minutes) 
Figure 28. Animal No. S3; treated with danofloxacin 
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Figure 29. Animal No. 54; treated with tilmicosin 
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Figure 30. Animal No. 5S; treated with tilmicosin 
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Figure 31. Animal No. 57; treated with danofloxacin 
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Figure 32. Animal No. 59; treated with tilmicosin 
